201
|
Liu W, Liu J, Song Y, Wang X, Mi L, Cai C, Zhao D, Wang L, Ma J, Zhu J. BURDEN OF LYMPHOMA IN CHINA, 1990−2019: AN ANALYSIS OF GLOBAL BURDEN OF DISEASES, INJURIES, AND RISK FACTORS STUDY 2019. Hematol Oncol 2021. [DOI: 10.1002/hon.194_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- W. Liu
- Peking University Cancer Hospital & Institute Department of Lymphoma Beijing China
| | - J. Liu
- National Center for Chronic and Noncommunicable Disease Control and Prevention Chinese Center for Disease Control and Prevention National Center for Chronic and Noncommunicable Disease Control and Prevention Beijing China
| | - Y. Song
- Peking University Cancer Hospital & Institute Department of Lymphoma Beijing China
| | - X. Wang
- Peking University Cancer Hospital & Institute Department of Lymphoma Beijing China
| | - L. Mi
- Peking University Cancer Hospital & Institute Department of Lymphoma Beijing China
| | - C. Cai
- Beijing Institute of Survey and Mapping Beijing Municipal Key Laboratory of Urban Spatial Information Engineering Beijing Institute of Survey and Mapping Beijing China
| | - D. Zhao
- Harbin Institute of Hematology & Oncology Harbin Institute of Hematology & Oncology Harbin China
| | - L. Wang
- National Center for Chronic and Noncommunicable Disease Control and Prevention Chinese Center for Disease Control and Prevention National Center for Chronic and Noncommunicable Disease Control and Prevention Beijing China
| | - J. Ma
- Harbin Institute of Hematology & Oncology Harbin Institute of Hematology & Oncology Harbin China
| | - J. Zhu
- Peking University Cancer Hospital & Institute Department of Lymphoma Beijing China
| |
Collapse
|
202
|
Xie Y, Mi L, Zheng W, Ping L, Lin N, Tu M, Zhang C, Ying Z, Liu W, Deng L, W M, Du T, Tang Y, Wang X, Zhu J, Song Y. CAMRELIZUMAB COMBINED WITH GEMOX IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA. Hematol Oncol 2021. [DOI: 10.1002/hon.104_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Y. Xie
- Key laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital & Institute Department of lymphoma beijing China
| | - L. Mi
- Key laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital & Institute Department of lymphoma beijing China
| | - W. Zheng
- Key laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital & Institute Department of lymphoma beijing China
| | - L. Ping
- Key laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital & Institute Department of lymphoma beijing China
| | - N. Lin
- Key laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital & Institute Department of lymphoma beijing China
| | - M. Tu
- Key laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital & Institute Department of lymphoma beijing China
| | - C. Zhang
- Key laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital & Institute Department of lymphoma beijing China
| | - Z. Ying
- Key laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital & Institute Department of lymphoma beijing China
| | - W. Liu
- Key laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital & Institute Department of lymphoma beijing China
| | - L. Deng
- Key laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital & Institute Department of lymphoma beijing China
| | - M. W
- Key laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital & Institute Department of lymphoma beijing China
| | - T. Du
- Key laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital & Institute Department of lymphoma beijing China
| | - Y. Tang
- Key laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital & Institute Department of lymphoma beijing China
| | - X. Wang
- Key laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital & Institute Department of lymphoma beijing China
| | - J. Zhu
- Key laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital & Institute Department of lymphoma beijing China
| | - Y. Song
- Key laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital & Institute Department of lymphoma beijing China
| |
Collapse
|
203
|
Wen W, Gu L, Zhao LW, Chen MY, Yang WQ, Liu W, Zhou X, Lai GX. [Diagnosis and treatment of Chlamydia psittaci pneumonia: experiences of 8 cases]. Zhonghua Jie He He Hu Xi Za Zhi 2021; 44:531-536. [PMID: 34102714 DOI: 10.3760/cma.j.cn112147-20210205-00097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: In order to improve the understanding and clinical treatment of Chlamydia psittaci pneumonia, we analyzed the clinical manifestations, laboratory test results and imaging features of 8 patients. Methods: We collected the clinical data of 8 patients with Chlamydia psittaci pneumonia diagnosed by metagenomic next-generation-sequencing (mNGS) from November 2018 to February 2020, including clinical features, chest CT scan, pathological features and antibiotic use. Results: A total of one male and 7 females, aged from 45 to 85 years(median 62 years), were included in this study. All the patients had high fever, cough and most had expectoration (6/8). The leukocyte count and PCT level were mostly normal (7/8). However, we observed decreased lymphocyte count(5/8), elevated C-reactive protein in all patients, and increased ESR in most patients (7/8). The chest CT of all the patients showed large patchy consolidation, with one case having pleural effusion. The pathological manifestations were nonspecific, showing infiltration of inflammatory cells and exudation. Moxifloxacin and/or doxycycline were administered after diagnosis, and the course of treatment lasted from 14 to 21 days.Chest CT showed absorption of lesions following treatment Conclusions: Chlamydia psittaci pneumonia showed certain characteristics, including high fever with pulmonary patchy consolidation, and normal white blood cell count. Molecular diagnostic methods such as mNGS could lead to rapid diagnosis and treatment which can shorten the course of hospitalization and thus improve prognosis.
Collapse
Affiliation(s)
- W Wen
- Department of Respiratory and Critical Care Medicine, Fuzhou General Hospital of Fujian Medical University, Dongfang Hospital of Xiamen University, the 900th Hospital of the Joint Logistic Support Force, PLA, Fuzhou 350025, China
| | - L Gu
- The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
| | - L W Zhao
- Department of Respiratory and Critical Care Medicine, Fuzhou General Hospital of Fujian Medical University, Dongfang Hospital of Xiamen University, the 900th Hospital of the Joint Logistic Support Force, PLA, Fuzhou 350025, China
| | - M Y Chen
- Department of Respiratory and Critical Care Medicine, Fuzhou General Hospital of Fujian Medical University, Dongfang Hospital of Xiamen University, the 900th Hospital of the Joint Logistic Support Force, PLA, Fuzhou 350025, China
| | - W Q Yang
- Department of Respiratory and Critical Care Medicine, Fuzhou General Hospital of Fujian Medical University, Dongfang Hospital of Xiamen University, the 900th Hospital of the Joint Logistic Support Force, PLA, Fuzhou 350025, China
| | - W Liu
- Department of Respiratory and Critical Care Medicine, Fuzhou General Hospital of Fujian Medical University, Dongfang Hospital of Xiamen University, the 900th Hospital of the Joint Logistic Support Force, PLA, Fuzhou 350025, China
| | - X Zhou
- Department of Respiratory and Critical Care Medicine, Fuzhou General Hospital of Fujian Medical University, Dongfang Hospital of Xiamen University, the 900th Hospital of the Joint Logistic Support Force, PLA, Fuzhou 350025, China
| | - G X Lai
- Department of Respiratory and Critical Care Medicine, Fuzhou General Hospital of Fujian Medical University, Dongfang Hospital of Xiamen University, the 900th Hospital of the Joint Logistic Support Force, PLA, Fuzhou 350025, China
| |
Collapse
|
204
|
Liu W, Liu J, Mi L, Cai C, Gong T, Ma J, Wang L. BURDEN OF MULTIPLE MYELOMA IN CHINA: AN ANALYSIS OF THE GLOBAL BURDEN OF DISEASE, INJURIES, AND RISK FACTORS STUDY 2019. Hematol Oncol 2021. [DOI: 10.1002/hon.107_2881] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- W. Liu
- Peking University Cancer Hospital & Institute Department of Lymphoma Beijing China
| | - J. Liu
- National Center for Chronic and Noncommunicable Disease Control and Prevention Chinese Center for Disease Control and Prevention National Center for Chronic and Noncommunicable Disease Control and Prevention Beijing China
| | - L. Mi
- Peking University Cancer Hospital & Institute Department of Lymphoma Beijing China
| | - C. Cai
- Beijing Institute of Survey and Mapping Beijing Municipal Key Laboratory of Urban Spatial Information Engineering Beijing Institute of Survey and Mapping Beijing China
| | - T. Gong
- Harbin Institute of Hematology & Oncology Harbin Institute of Hematology & Oncology Harbin China
| | - J. Ma
- Harbin Institute of Hematology & Oncology Harbin Institute of Hematology & Oncology Harbin China
| | - L. Wang
- National Center for Chronic and Noncommunicable Disease Control and Prevention Chinese Center for Disease Control and Prevention National Center for Chronic and Noncommunicable Disease Control and Prevention Beijing China
| |
Collapse
|
205
|
Yu H, Liu W, Mi L, Shu S, Zhang W, Ying Z, Chen H, Yan X, Shen W, Tu G, Ye Y, Li M, Wang D, Hu D, Cao J, Qi F, Wang X, Song Y, Zhu J. THE CD19/CD3 BISPECIFIC ANTIBODY WORK EFFECTIVELY AS ADJUNCT WITH IBRUTINIB ON THE TREATMENT OF B‐CELL LYMPHOMA. Hematol Oncol 2021. [DOI: 10.1002/hon.77_2881] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- H. Yu
- Beijing Cancer Hospital Lymphoma Beijing China
| | - W. Liu
- Beijing Cancer Hospital Lymphoma Beijing China
| | - L. Mi
- Beijing Cancer Hospital Lymphoma Beijing China
| | - S. Shu
- Beijing Cancer Hospital Lymphoma Beijing China
| | - W. Zhang
- Beijing Cancer Hospital Molecular Oncology Laboratory Beijing China
| | - Z. Ying
- Beijing Cancer Hospital Lymphoma Beijing China
| | - H. Chen
- ITabMed Ltd Preclinical Research Shanghai China
| | - X. Yan
- ITabMed Ltd Preclinical Research Shanghai China
| | - W. Shen
- ITabMed Ltd Preclinical Research Shanghai China
| | - G. Tu
- ITabMed Ltd Preclinical Research Shanghai China
| | - Y. Ye
- Beijing Cancer Hospital Lymphoma Beijing China
| | - M. Li
- Beijing Cancer Hospital Lymphoma Beijing China
| | - D. Wang
- Beijing Cancer Hospital Lymphoma Beijing China
| | - D. Hu
- Beijing Cancer Hospital Lymphoma Beijing China
| | - J. Cao
- Beijing Cancer Hospital Lymphoma Beijing China
| | - F. Qi
- Beijing Cancer Hospital Lymphoma Beijing China
| | - X. Wang
- Beijing Cancer Hospital Lymphoma Beijing China
| | - Y. Song
- Beijing Cancer Hospital Lymphoma Beijing China
| | - J. Zhu
- Beijing Cancer Hospital Lymphoma Beijing China
| |
Collapse
|
206
|
Cao Z, Aharonian FA, An Q, Axikegu, Bai LX, Bai YX, Bao YW, Bastieri D, Bi XJ, Bi YJ, Cai H, Cai JT, Cao Z, Chang J, Chang JF, Chang XC, Chen BM, Chen J, Chen L, Chen L, Chen L, Chen MJ, Chen ML, Chen QH, Chen SH, Chen SZ, Chen TL, Chen XL, Chen Y, Cheng N, Cheng YD, Cui SW, Cui XH, Cui YD, Dai BZ, Dai HL, Dai ZG, Danzengluobu, Della Volpe D, D Ettorre Piazzoli B, Dong XJ, Fan JH, Fan YZ, Fan ZX, Fang J, Fang K, Feng CF, Feng L, Feng SH, Feng YL, Gao B, Gao CD, Gao Q, Gao W, Ge MM, Geng LS, Gong GH, Gou QB, Gu MH, Guo JG, Guo XL, Guo YQ, Guo YY, Han YA, He HH, He HN, He JC, He SL, He XB, He Y, Heller M, Hor YK, Hou C, Hou X, Hu HB, Hu S, Hu SC, Hu XJ, Huang DH, Huang QL, Huang WH, Huang XT, Huang ZC, Ji F, Ji XL, Jia HY, Jiang K, Jiang ZJ, Jin C, Kuleshov D, Levochkin K, Li BB, Li C, Li C, Li F, Li HB, Li HC, Li HY, Li J, Li K, Li WL, Li X, Li X, Li XR, Li Y, Li YZ, Li Z, Li Z, Liang EW, Liang YF, Lin SJ, Liu B, Liu C, Liu D, Liu H, Liu HD, Liu J, Liu JL, Liu JS, Liu JY, Liu MY, Liu RY, Liu SM, Liu W, Liu YN, Liu ZX, Long WJ, Lu R, Lv HK, Ma BQ, Ma LL, Ma XH, Mao JR, Masood A, Mitthumsiri W, Montaruli T, Nan YC, Pang BY, Pattarakijwanich P, Pei ZY, Qi MY, Ruffolo D, Rulev V, Sáiz A, Shao L, Shchegolev O, Sheng XD, Shi JR, Song HC, Stenkin YV, Stepanov V, Sun QN, Sun XN, Sun ZB, Tam PHT, Tang ZB, Tian WW, Wang BD, Wang C, Wang H, Wang HG, Wang JC, Wang JS, Wang LP, Wang LY, Wang RN, Wang W, Wang W, Wang XG, Wang XJ, Wang XY, Wang YD, Wang YJ, Wang YP, Wang Z, Wang Z, Wang ZH, Wang ZX, Wei DM, Wei JJ, Wei YJ, Wen T, Wu CY, Wu HR, Wu S, Wu WX, Wu XF, Xi SQ, Xia J, Xia JJ, Xiang GM, Xiao G, Xiao HB, Xin GG, Xin YL, Xing Y, Xu DL, Xu RX, Xue L, Yan DH, Yang CW, Yang FF, Yang JY, Yang LL, Yang MJ, Yang RZ, Yang SB, Yao YH, Yao ZG, Ye YM, Yin LQ, Yin N, You XH, You ZY, Yu YH, Yuan Q, Zeng HD, Zeng TX, Zeng W, Zeng ZK, Zha M, Zhai XX, Zhang BB, Zhang HM, Zhang HY, Zhang JL, Zhang JW, Zhang L, Zhang L, Zhang LX, Zhang PF, Zhang PP, Zhang R, Zhang SR, Zhang SS, Zhang X, Zhang XP, Zhang Y, Zhang Y, Zhang YF, Zhang YL, Zhao B, Zhao J, Zhao L, Zhao LZ, Zhao SP, Zheng F, Zheng Y, Zhou B, Zhou H, Zhou JN, Zhou P, Zhou R, Zhou XX, Zhu CG, Zhu FR, Zhu H, Zhu KJ, Zuo X. Ultrahigh-energy photons up to 1.4 petaelectronvolts from 12 γ-ray Galactic sources. Nature 2021; 594:33-36. [PMID: 34002091 DOI: 10.1038/s41586-021-03498-z] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2020] [Accepted: 03/26/2021] [Indexed: 02/04/2023]
Abstract
The extension of the cosmic-ray spectrum beyond 1 petaelectronvolt (PeV; 1015 electronvolts) indicates the existence of the so-called PeVatrons-cosmic-ray factories that accelerate particles to PeV energies. We need to locate and identify such objects to find the origin of Galactic cosmic rays1. The principal signature of both electron and proton PeVatrons is ultrahigh-energy (exceeding 100 TeV) γ radiation. Evidence of the presence of a proton PeVatron has been found in the Galactic Centre, according to the detection of a hard-spectrum radiation extending to 0.04 PeV (ref. 2). Although γ-rays with energies slightly higher than 0.1 PeV have been reported from a few objects in the Galactic plane3-6, unbiased identification and in-depth exploration of PeVatrons requires detection of γ-rays with energies well above 0.1 PeV. Here we report the detection of more than 530 photons at energies above 100 teraelectronvolts and up to 1.4 PeV from 12 ultrahigh-energy γ-ray sources with a statistical significance greater than seven standard deviations. Despite having several potential counterparts in their proximity, including pulsar wind nebulae, supernova remnants and star-forming regions, the PeVatrons responsible for the ultrahigh-energy γ-rays have not yet been firmly localized and identified (except for the Crab Nebula), leaving open the origin of these extreme accelerators.
Collapse
Affiliation(s)
- Zhen Cao
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China. .,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China. .,University of Chinese Academy of Sciences, Beijing, China.
| | - F A Aharonian
- Dublin Institute for Advanced Studies, Dublin, Ireland. .,Max-Planck-Institut for Nuclear Physics, Heidelberg, Germany.
| | - Q An
- State Key Laboratory of Particle Detection and Electronics, Beijing, China.,University of Science and Technology of China, Hefei, China
| | - Axikegu
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - L X Bai
- College of Physics, Sichuan University, Chengdu, China
| | - Y X Bai
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y W Bao
- School of Astronomy and Space Science, Nanjing University, Nanjing, China
| | - D Bastieri
- Center for Astrophysics, Guangzhou University, Guangzhou, China
| | - X J Bi
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,University of Chinese Academy of Sciences, Beijing, China
| | - Y J Bi
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H Cai
- School of Physics and Technology, Wuhan University, Wuhan, China
| | - J T Cai
- Center for Astrophysics, Guangzhou University, Guangzhou, China
| | - Zhe Cao
- State Key Laboratory of Particle Detection and Electronics, Beijing, China.,University of Science and Technology of China, Hefei, China
| | - J Chang
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China
| | - J F Chang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,State Key Laboratory of Particle Detection and Electronics, Beijing, China
| | - X C Chang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - B M Chen
- Hebei Normal University, Shijiazhuang, China
| | - J Chen
- College of Physics, Sichuan University, Chengdu, China
| | - L Chen
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,University of Chinese Academy of Sciences, Beijing, China
| | - Liang Chen
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, Shanghai, China
| | - Long Chen
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - M J Chen
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - M L Chen
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,State Key Laboratory of Particle Detection and Electronics, Beijing, China
| | - Q H Chen
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - S H Chen
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,University of Chinese Academy of Sciences, Beijing, China
| | - S Z Chen
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China. .,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.
| | - T L Chen
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, Lhasa, Tibet, China
| | - X L Chen
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,University of Chinese Academy of Sciences, Beijing, China
| | - Y Chen
- School of Astronomy and Space Science, Nanjing University, Nanjing, China
| | - N Cheng
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y D Cheng
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - S W Cui
- Hebei Normal University, Shijiazhuang, China
| | - X H Cui
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing, China
| | - Y D Cui
- School of Physics and Astronomy & School of Physics (Guangzhou), Sun Yat-sen University, Zhuhai, China
| | - B Z Dai
- School of Physics and Astronomy, Yunnan University, Kunming, China
| | - H L Dai
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China
| | - Z G Dai
- School of Astronomy and Space Science, Nanjing University, Nanjing, China
| | - Danzengluobu
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, Lhasa, Tibet, China
| | - D Della Volpe
- Département de Physique Nucléaire et Corpusculaire, Faculté de Sciences, Université de Genève, Geneva, Switzerland
| | - B D Ettorre Piazzoli
- Dipartimento di Fisica dell'Università di Napoli "Federico II", Complesso Universitario di Monte Sant'Angelo, Naples, Italy
| | - X J Dong
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J H Fan
- Center for Astrophysics, Guangzhou University, Guangzhou, China
| | - Y Z Fan
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China
| | - Z X Fan
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J Fang
- School of Physics and Astronomy, Yunnan University, Kunming, China
| | - K Fang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - C F Feng
- Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, China
| | - L Feng
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China
| | - S H Feng
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y L Feng
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China
| | - B Gao
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - C D Gao
- Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, China
| | - Q Gao
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, Lhasa, Tibet, China
| | - W Gao
- Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, China
| | - M M Ge
- School of Physics and Astronomy, Yunnan University, Kunming, China
| | - L S Geng
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - G H Gong
- Department of Engineering Physics, Tsinghua University, Beijing, China
| | - Q B Gou
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - M H Gu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,State Key Laboratory of Particle Detection and Electronics, Beijing, China
| | - J G Guo
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,University of Chinese Academy of Sciences, Beijing, China
| | - X L Guo
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - Y Q Guo
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y Y Guo
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,University of Chinese Academy of Sciences, Beijing, China.,Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China
| | - Y A Han
- School of Physics and Microelectronics, Zhengzhou University, Zhengzhou, China
| | - H H He
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,University of Chinese Academy of Sciences, Beijing, China
| | - H N He
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China
| | - J C He
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,University of Chinese Academy of Sciences, Beijing, China
| | - S L He
- Center for Astrophysics, Guangzhou University, Guangzhou, China
| | - X B He
- School of Physics and Astronomy & School of Physics (Guangzhou), Sun Yat-sen University, Zhuhai, China
| | - Y He
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - M Heller
- Département de Physique Nucléaire et Corpusculaire, Faculté de Sciences, Université de Genève, Geneva, Switzerland
| | - Y K Hor
- School of Physics and Astronomy & School of Physics (Guangzhou), Sun Yat-sen University, Zhuhai, China
| | - C Hou
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X Hou
- Yunnan Observatories, Chinese Academy of Sciences, Kunming, China
| | - H B Hu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,University of Chinese Academy of Sciences, Beijing, China
| | - S Hu
- College of Physics, Sichuan University, Chengdu, China
| | - S C Hu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,University of Chinese Academy of Sciences, Beijing, China
| | - X J Hu
- Department of Engineering Physics, Tsinghua University, Beijing, China
| | - D H Huang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - Q L Huang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - W H Huang
- Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, China
| | - X T Huang
- Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, China
| | - Z C Huang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - F Ji
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X L Ji
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,State Key Laboratory of Particle Detection and Electronics, Beijing, China
| | - H Y Jia
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - K Jiang
- State Key Laboratory of Particle Detection and Electronics, Beijing, China.,University of Science and Technology of China, Hefei, China
| | - Z J Jiang
- School of Physics and Astronomy, Yunnan University, Kunming, China
| | - C Jin
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,University of Chinese Academy of Sciences, Beijing, China
| | - D Kuleshov
- Institute for Nuclear Research of Russian Academy of Sciences, Moscow, Russia
| | - K Levochkin
- Institute for Nuclear Research of Russian Academy of Sciences, Moscow, Russia
| | - B B Li
- Hebei Normal University, Shijiazhuang, China
| | - Cong Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Cheng Li
- State Key Laboratory of Particle Detection and Electronics, Beijing, China.,University of Science and Technology of China, Hefei, China
| | - F Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,State Key Laboratory of Particle Detection and Electronics, Beijing, China
| | - H B Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H C Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H Y Li
- University of Science and Technology of China, Hefei, China.,Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China
| | - J Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,State Key Laboratory of Particle Detection and Electronics, Beijing, China
| | - K Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - W L Li
- Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, China
| | - X Li
- State Key Laboratory of Particle Detection and Electronics, Beijing, China.,University of Science and Technology of China, Hefei, China
| | - Xin Li
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - X R Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y Li
- College of Physics, Sichuan University, Chengdu, China
| | - Y Z Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,University of Chinese Academy of Sciences, Beijing, China
| | - Zhe Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Zhuo Li
- School of Physics, Peking University, Beijing, China
| | - E W Liang
- School of Physical Science and Technology, Guangxi University, Nanning, China
| | - Y F Liang
- School of Physical Science and Technology, Guangxi University, Nanning, China
| | - S J Lin
- School of Physics and Astronomy & School of Physics (Guangzhou), Sun Yat-sen University, Zhuhai, China
| | - B Liu
- University of Science and Technology of China, Hefei, China
| | - C Liu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - D Liu
- Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, China
| | - H Liu
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - H D Liu
- School of Physics and Microelectronics, Zhengzhou University, Zhengzhou, China
| | - J Liu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J L Liu
- Tsung-Dao Lee Institute, Shanghai Jiao Tong University, Shanghai, China.,School of Physics and Astronomy, Shanghai Jiao Tong University, Shanghai, China
| | - J S Liu
- School of Physics and Astronomy & School of Physics (Guangzhou), Sun Yat-sen University, Zhuhai, China
| | - J Y Liu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - M Y Liu
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, Lhasa, Tibet, China
| | - R Y Liu
- School of Astronomy and Space Science, Nanjing University, Nanjing, China.
| | - S M Liu
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China
| | - W Liu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y N Liu
- Department of Engineering Physics, Tsinghua University, Beijing, China
| | - Z X Liu
- College of Physics, Sichuan University, Chengdu, China
| | - W J Long
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - R Lu
- School of Physics and Astronomy, Yunnan University, Kunming, China
| | - H K Lv
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - B Q Ma
- School of Physics, Peking University, Beijing, China
| | - L L Ma
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X H Ma
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J R Mao
- Yunnan Observatories, Chinese Academy of Sciences, Kunming, China
| | - A Masood
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - W Mitthumsiri
- Department of Physics, Faculty of Science, Mahidol University, Bangkok, Thailand
| | - T Montaruli
- Département de Physique Nucléaire et Corpusculaire, Faculté de Sciences, Université de Genève, Geneva, Switzerland
| | - Y C Nan
- Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, China
| | - B Y Pang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - P Pattarakijwanich
- Department of Physics, Faculty of Science, Mahidol University, Bangkok, Thailand
| | - Z Y Pei
- Center for Astrophysics, Guangzhou University, Guangzhou, China
| | - M Y Qi
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - D Ruffolo
- Department of Physics, Faculty of Science, Mahidol University, Bangkok, Thailand
| | - V Rulev
- Institute for Nuclear Research of Russian Academy of Sciences, Moscow, Russia
| | - A Sáiz
- Department of Physics, Faculty of Science, Mahidol University, Bangkok, Thailand
| | - L Shao
- Hebei Normal University, Shijiazhuang, China
| | - O Shchegolev
- Institute for Nuclear Research of Russian Academy of Sciences, Moscow, Russia.,Moscow Institute of Physics and Technology, Moscow, Russia
| | - X D Sheng
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J R Shi
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H C Song
- School of Physics, Peking University, Beijing, China
| | - Yu V Stenkin
- Institute for Nuclear Research of Russian Academy of Sciences, Moscow, Russia.,Moscow Institute of Physics and Technology, Moscow, Russia
| | - V Stepanov
- Institute for Nuclear Research of Russian Academy of Sciences, Moscow, Russia
| | - Q N Sun
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - X N Sun
- School of Physical Science and Technology, Guangxi University, Nanning, China
| | - Z B Sun
- National Space Science Center, Chinese Academy of Sciences, Beijing, China
| | - P H T Tam
- School of Physics and Astronomy & School of Physics (Guangzhou), Sun Yat-sen University, Zhuhai, China
| | - Z B Tang
- State Key Laboratory of Particle Detection and Electronics, Beijing, China.,University of Science and Technology of China, Hefei, China
| | - W W Tian
- University of Chinese Academy of Sciences, Beijing, China.,National Astronomical Observatories, Chinese Academy of Sciences, Beijing, China
| | - B D Wang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - C Wang
- National Space Science Center, Chinese Academy of Sciences, Beijing, China
| | - H Wang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - H G Wang
- Center for Astrophysics, Guangzhou University, Guangzhou, China
| | - J C Wang
- Yunnan Observatories, Chinese Academy of Sciences, Kunming, China
| | - J S Wang
- Tsung-Dao Lee Institute, Shanghai Jiao Tong University, Shanghai, China.,School of Physics and Astronomy, Shanghai Jiao Tong University, Shanghai, China
| | - L P Wang
- Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, China
| | - L Y Wang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - R N Wang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - W Wang
- School of Physics and Astronomy & School of Physics (Guangzhou), Sun Yat-sen University, Zhuhai, China
| | - W Wang
- School of Physics and Technology, Wuhan University, Wuhan, China
| | - X G Wang
- School of Physical Science and Technology, Guangxi University, Nanning, China
| | - X J Wang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X Y Wang
- School of Astronomy and Space Science, Nanjing University, Nanjing, China
| | - Y D Wang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y J Wang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y P Wang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,University of Chinese Academy of Sciences, Beijing, China
| | - Zheng Wang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,State Key Laboratory of Particle Detection and Electronics, Beijing, China
| | - Zhen Wang
- Tsung-Dao Lee Institute, Shanghai Jiao Tong University, Shanghai, China.,School of Physics and Astronomy, Shanghai Jiao Tong University, Shanghai, China
| | - Z H Wang
- College of Physics, Sichuan University, Chengdu, China
| | - Z X Wang
- School of Physics and Astronomy, Yunnan University, Kunming, China
| | - D M Wei
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China
| | - J J Wei
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China
| | - Y J Wei
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,University of Chinese Academy of Sciences, Beijing, China
| | - T Wen
- School of Physics and Astronomy, Yunnan University, Kunming, China
| | - C Y Wu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H R Wu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - S Wu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - W X Wu
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - X F Wu
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China
| | - S Q Xi
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - J Xia
- University of Science and Technology of China, Hefei, China.,Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China
| | - J J Xia
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - G M Xiang
- University of Chinese Academy of Sciences, Beijing, China.,Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, Shanghai, China
| | - G Xiao
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H B Xiao
- Center for Astrophysics, Guangzhou University, Guangzhou, China
| | - G G Xin
- School of Physics and Technology, Wuhan University, Wuhan, China
| | - Y L Xin
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - Y Xing
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, Shanghai, China
| | - D L Xu
- Tsung-Dao Lee Institute, Shanghai Jiao Tong University, Shanghai, China.,School of Physics and Astronomy, Shanghai Jiao Tong University, Shanghai, China
| | - R X Xu
- School of Physics, Peking University, Beijing, China
| | - L Xue
- Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, China
| | - D H Yan
- Yunnan Observatories, Chinese Academy of Sciences, Kunming, China
| | - C W Yang
- College of Physics, Sichuan University, Chengdu, China
| | - F F Yang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,State Key Laboratory of Particle Detection and Electronics, Beijing, China
| | - J Y Yang
- School of Physics and Astronomy & School of Physics (Guangzhou), Sun Yat-sen University, Zhuhai, China
| | - L L Yang
- School of Physics and Astronomy & School of Physics (Guangzhou), Sun Yat-sen University, Zhuhai, China
| | - M J Yang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - R Z Yang
- University of Science and Technology of China, Hefei, China.
| | - S B Yang
- School of Physics and Astronomy, Yunnan University, Kunming, China
| | - Y H Yao
- College of Physics, Sichuan University, Chengdu, China
| | - Z G Yao
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y M Ye
- Department of Engineering Physics, Tsinghua University, Beijing, China
| | - L Q Yin
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - N Yin
- Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, China
| | - X H You
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Z Y You
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,University of Chinese Academy of Sciences, Beijing, China
| | - Y H Yu
- Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, China
| | - Q Yuan
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China
| | - H D Zeng
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China
| | - T X Zeng
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,State Key Laboratory of Particle Detection and Electronics, Beijing, China
| | - W Zeng
- School of Physics and Astronomy, Yunnan University, Kunming, China
| | - Z K Zeng
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,University of Chinese Academy of Sciences, Beijing, China
| | - M Zha
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X X Zhai
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - B B Zhang
- School of Astronomy and Space Science, Nanjing University, Nanjing, China
| | - H M Zhang
- School of Astronomy and Space Science, Nanjing University, Nanjing, China
| | - H Y Zhang
- Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, China
| | - J L Zhang
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing, China
| | - J W Zhang
- College of Physics, Sichuan University, Chengdu, China
| | - L Zhang
- Hebei Normal University, Shijiazhuang, China
| | - Li Zhang
- School of Physics and Astronomy, Yunnan University, Kunming, China
| | - L X Zhang
- Center for Astrophysics, Guangzhou University, Guangzhou, China
| | - P F Zhang
- School of Physics and Astronomy, Yunnan University, Kunming, China
| | - P P Zhang
- Hebei Normal University, Shijiazhuang, China
| | - R Zhang
- University of Science and Technology of China, Hefei, China.,Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China
| | - S R Zhang
- Hebei Normal University, Shijiazhuang, China
| | - S S Zhang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X Zhang
- School of Astronomy and Space Science, Nanjing University, Nanjing, China
| | - X P Zhang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Yong Zhang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Yi Zhang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China
| | - Y F Zhang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - Y L Zhang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - B Zhao
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - J Zhao
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - L Zhao
- State Key Laboratory of Particle Detection and Electronics, Beijing, China.,University of Science and Technology of China, Hefei, China
| | - L Z Zhao
- Hebei Normal University, Shijiazhuang, China
| | - S P Zhao
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing, China.,Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, China
| | - F Zheng
- National Space Science Center, Chinese Academy of Sciences, Beijing, China
| | - Y Zheng
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - B Zhou
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H Zhou
- Tsung-Dao Lee Institute, Shanghai Jiao Tong University, Shanghai, China.,School of Physics and Astronomy, Shanghai Jiao Tong University, Shanghai, China
| | - J N Zhou
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, Shanghai, China
| | - P Zhou
- School of Astronomy and Space Science, Nanjing University, Nanjing, China
| | - R Zhou
- College of Physics, Sichuan University, Chengdu, China
| | - X X Zhou
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - C G Zhu
- Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao, China
| | - F R Zhu
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, Chengdu, China
| | - H Zhu
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing, China
| | - K J Zhu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China.,University of Chinese Academy of Sciences, Beijing, China.,State Key Laboratory of Particle Detection and Electronics, Beijing, China
| | - X Zuo
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.,TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| |
Collapse
|
207
|
Yang J, Sun Y, Xu F, Liu W, Hayashi T, Mizuno K, Hattori S, Fujisaki H, Ikejima T. Autophagy and glycolysis independently attenuate silibinin-induced apoptosis in human hepatocarcinoma HepG2 and Hep3B cells. Hum Exp Toxicol 2021; 40:2048-2062. [PMID: 34053323 DOI: 10.1177/09603271211017609] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
PURPOSE The mechanism of cytotoxicity of silibinin on two human hepatocellular carcinoma (HCC) cell lines, HepG2 (p53 wild-type) and Hep3B cells (p53 null), is examined in relation with the induction of autophagy and phosphorylation of AMP-activated protein kinase (p-AMPK). MATERIALS AND METHODS Levels of apoptosis in relation to the levels of autophagy and those of glycolysis-related proteins, glucose transporter 1/4 (Glut1/4) and hexokinase-II (HK2), in HepG2 and Hep3B cells were examined. RESULTS Silibinin-induced apoptosis was incomplete for HCC cell death in that up-regulated autophagy and/or reduced level of glycolysis, which are induced by silibinin treatment, antagonized silibinin-induced apoptosis. Inhibition of autophagy with 3-methyl adenine (3MA) or blocking of AMP-activated protein kinase (AMPK) activation with Compound C (CC) enhanced silibinin-induced apoptosis. The results confirm that AMPK involved in autophagy as well as in glycolysis remaining with silibinin is responsible for attenuation of silibinin-induced apoptosis. Blocking of AMPK or autophagy contributes to the enhancement of silibinin's cytotoxicity to HepG2 and Hep3B cells. CONCLUSION This study shows that incomplete apoptosis of HCC by silibinin treatment becomes complete by repression of autophagy and/or glycolysis.
Collapse
Affiliation(s)
- J Yang
- Department of Pharmacy, 159411The Third People's Hospital of Chengdu, Chengdu, Sichuan, People's Republic of China.,Wuya College of Innovation, 58575Shenyang Pharmaceutical University, Shenyang, Liaoning, People's Republic of China
| | - Y Sun
- Wuya College of Innovation, 58575Shenyang Pharmaceutical University, Shenyang, Liaoning, People's Republic of China
| | - F Xu
- Wuya College of Innovation, 58575Shenyang Pharmaceutical University, Shenyang, Liaoning, People's Republic of China
| | - W Liu
- Wuya College of Innovation, 58575Shenyang Pharmaceutical University, Shenyang, Liaoning, People's Republic of China
| | - T Hayashi
- Wuya College of Innovation, 58575Shenyang Pharmaceutical University, Shenyang, Liaoning, People's Republic of China.,Department of Chemistry and Life Science, School of Advanced Engineering, Kogakuin University, Hachioji, Tokyo, Japan.,Nippi Research Institute of Biomatrix, Toride, Ibaraki, Japan
| | - K Mizuno
- Nippi Research Institute of Biomatrix, Toride, Ibaraki, Japan
| | - S Hattori
- Nippi Research Institute of Biomatrix, Toride, Ibaraki, Japan
| | - H Fujisaki
- Nippi Research Institute of Biomatrix, Toride, Ibaraki, Japan
| | - T Ikejima
- Wuya College of Innovation, 58575Shenyang Pharmaceutical University, Shenyang, Liaoning, People's Republic of China.,Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, 58575Shenyang Pharmaceutical University, Shenyang, Liaoning, People's Republic of China
| |
Collapse
|
208
|
Zhou R, Zhang X, Huang L, Zhu X, Dong M, Liu W, Wang S, Liu F. Association between serum estradiol levels prior to progesterone administration in artificial frozen-thawed blastocyst transfer cycles and live birth rate: a retrospective study. BJOG 2021; 128:2092-2100. [PMID: 34047447 DOI: 10.1111/1471-0528.16777] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/23/2021] [Indexed: 11/29/2022]
Abstract
OBJECTIVE To study whether serum estradiol (E2) levels prior to progesterone administration in the artificial endometrial preparation (AEP) of frozen-thawed blastocyst transfer affect the live birth rate. DESIGN Retrospective cohort study. SETTING Tertiary-care academic medical centre. POPULATION A total of 3857 frozen-thawed blastocyst transfer cycles were divided into three groups: <200 pg/ml (n = 1676); 200-399 pg/ml (n = 1296); and ≥400 pg/ml (n = 885), based on the 25th (182.3 pg/ml) and 75th percentile (390.2 pg/ml) of serum E2 level prior to progesterone administration. METHODS Univariable and multivariable logistic regression analysis was performed. MAIN OUTCOME MEASURES The primary outcome of the study was the live birth rate and the secondary outcomes included clinical pregnancy rate, pregnancy loss rate, neonatal birthweight, Z-score, and small for gestational age (SGA). RESULTS Compared with the reference group, accounting for major covariates, the live birth rate significantly decreased in the '≥400 pg/ml' group (adjusted OR 0.71, 95% CI 0.59-0.85). Compared with the reference group, there was an association between the E2 level in the '≥400 pg/ml' group and a decrease in the clinical pregnancy rate (adjusted OR 0.74, 95% CI 0.61-0.89). Compared with the reference group, the pregnancy loss rate significantly increased in the '≥400 pg/ml' group (adjusted OR 1.45, 95% CI 1.08-1.93). The E2 levels did not affect neonatal birthweight, Z-score, and SGA among singletons. CONCLUSIONS High serum E2 levels prior to progesterone administration in AEP are associated with a decreased live birth rate after frozen-thawed blastocyst transfer. TWEETABLE ABSTRACT High serum E2 levels prior to progesterone administration in artificial FET are associated with a decreased live birth rate after frozen-thawed blastocyst transfer.
Collapse
Affiliation(s)
- R Zhou
- Center for Reproductive Medicine, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China
| | - X Zhang
- Center for Reproductive Medicine, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China
| | - L Huang
- Center for Reproductive Medicine, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China
| | - X Zhu
- Center for Reproductive Medicine, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China
| | - M Dong
- Center for Reproductive Medicine, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China
| | - W Liu
- Center for Reproductive Medicine, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China
| | - S Wang
- Center for Reproductive Medicine, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China
| | - F Liu
- Center for Reproductive Medicine, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China
| |
Collapse
|
209
|
Abstract
Background Aniridia is a kind of congenital human pan-ocular anomaly, which is related to PAX6 commonly. Methods The ophthalmic examinations including visual acuity, slit lamp and fundoscopy examination were performed in a Chinese aniridia pedigree. The targeted next-generation sequencing of aniridia genes was used to identify the causative mutation. Results A novel heterozygous PAX6 nonsense mutation c.619A > T (p.K207*) was identified in the Chinese autosomal dominant family with aniridia. Phenotype related to the novel mutation included nystagmus, keratopathy, absence of iris, cataract and foveal hypoplasia. Conclusions The novel nonsense variation in PAX6 was the cause of aniridia in this family, which expanded the spectrum of the PAX6 mutation.
Collapse
Affiliation(s)
- X Jin
- Department of Ophthalmology, Chinese PLA General Hospital, 100853, Beijing, China
| | - W Liu
- Department of Ophthalmology, Hainan Hospital of Chinese PLA General Hospital, 572000, Sanya, Hainan Province, China
| | - L H Qv
- Department of Ophthalmology, the 74th Army Group Hospital, 510318, Guangzhou, China
| | - W Q X
- Department of Ophthalmology, Chinese PLA General Hospital, 100853, Beijing, China
| | - H B Huang
- Department of Ophthalmology, Chinese PLA General Hospital, 100853, Beijing, China. .,Department of Ophthalmology, Hainan Hospital of Chinese PLA General Hospital, 572000, Sanya, Hainan Province, China. .,The Second School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China.
| |
Collapse
|
210
|
Tian DZ, Teng DH, Yu Y, Li JJ, Jiang WT, Gao W, Cai JZ, Zhang YM, Ma N, Yu WL, Weng YQ, Li DH, Liu W, Zhou YH, Zheng H. [Initial exploration of transfusion-free liver transplantation]. Zhonghua Wai Ke Za Zhi 2021; 59:348-352. [PMID: 33915624 DOI: 10.3760/cma.j.cn112139-20200525-00410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate the effect of transfusion-free techniques on the prognosis of liver transplant patients. Methods: The recipients of adult liver transplantation at Tianjin First Central Hospital from August to December 2019 were included in the clinical observation. Liver transplantation without allogeneic blood transfusion was performed through anesthesia management techniques such as acute hemodilution or phlebotomy without volume replacement,maintaining decreased baseline central venous pressure and cell saver. According to the actual results,the patients were divided into two groups: transfusion-free group(n=21) and allogeneic transfusion group(n=28). There were 13 males and 8 females aged of (56.3±11.6) years in the transfusion-free group;and there were 16 males and 12 females aged (54.3±14.2)years in the allogeneic transfusion group. The transplant recipients who had not adopted transfusion management strategy from January to July 2019 were included as control group(27 males and 13 females,aged of (58.9±14.1)years). The clinical data of patients in perioperative period were collected to compare whether there were differences in the recovery of liver function and early complications among the three groups, one-way ANOVA test, rank-sum test, and χ2 test were used for data analysis. Results: The amount of intraoperative blood loss in both the transfusion-free group and the transfusion group was less than that in the control group((454.2±271.3)ml vs.(673.6±333.4)ml vs.(890.3±346.7)ml;q=-6.342,-5.286,both P<0.05).The duration of stay in ICU of the transfusion-free group was less than that of the transfusion group and control group((36.4±9.1)hours vs.(44.3±14.9)hours vs.(58.2±21.1)hours;q=-4.432,-3.824,both P<0.05).The mean ALT level at 7 days after operation was significantly lower in the transfusion-free group than in the control group((56.8±32.1)U/L vs.(89.6±45.6)U/L;q=-3.358,P<0.05). Conclusions: The improvement of multi-disciplinary transfusion management technology aimed at transfusion-free liver transplantation can effectively reduce intraoperative hemorrhage and help to avoid surgical transfusion. Transfusion-free liver transplantation is beneficial to the early postoperative recovery,and its long-term clinical significance is worthy of further clinical research.
Collapse
Affiliation(s)
- D Z Tian
- Organ Transplant Center,Tianjin First Central Hospital,Tianjin 300192,China
| | - D H Teng
- Organ Transplant Center,Tianjin First Central Hospital,Tianjin 300192,China
| | - Y Yu
- Organ Transplant Center,Tianjin First Central Hospital,Tianjin 300192,China
| | - J J Li
- Organ Transplant Center,Tianjin First Central Hospital,Tianjin 300192,China
| | - W T Jiang
- Organ Transplant Center,Tianjin First Central Hospital,Tianjin 300192,China
| | - W Gao
- Organ Transplant Center,Tianjin First Central Hospital,Tianjin 300192,China
| | - J Z Cai
- Organ Transplant Center,Tianjin First Central Hospital,Tianjin 300192,China
| | - Y M Zhang
- Department of Hepatobiliary Surgery,Tianjin First Central Hospital,Tianjin 300192,China
| | - N Ma
- Organ Transplant Center,Tianjin First Central Hospital,Tianjin 300192,China
| | - W L Yu
- Department of Anesthesiology,Tianjin First Central Hospital,Tianjin 300192,China
| | - Y Q Weng
- Department of Anesthesiology,Tianjin First Central Hospital,Tianjin 300192,China
| | - D H Li
- Department of Transfusion,Tianjin First Central Hospital,Tianjin 300192,China
| | - W Liu
- Department of Transfusion,Tianjin First Central Hospital,Tianjin 300192,China
| | - Y H Zhou
- Tianjin Medical University First center Clinical College,Tianjin 300192,China
| | - H Zheng
- Organ Transplant Center,Tianjin First Central Hospital,Tianjin 300192,China
| |
Collapse
|
211
|
Li SM, Wang YA, Liu W, Wu ZY, Chen L, Cai XL, Zhang R, Yang WJ, Liu Y, Ma YM, Gong SQ, Zhang SM, Ren Q, Han XY, Ji LN. [Urinary retinol binding protein and β 2-microglobulin were associated with urinary albumin to creatinine ratio and renal function in hospitalized diabetic patients]. Zhonghua Nei Ke Za Zhi 2021; 60:438-445. [PMID: 33906273 DOI: 10.3760/cma.j.cn112138-20200515-00483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the associations of urinary retinol binding protein (RBP) and β2-microglobulin (β2-MG) with urinary albumin to creatinine ratio (UACR) and renal function in hospitalized patients with type 2 diabetes mellitus (T2DM). Methods: A total of 1 030 Chinese patients with T2DM were included in this study. The subjects were divided into the UACR normal group (<30 mg/g), microalbuminuria group (30-300 mg/g) and macroalbuminuria group (>300 mg/g). Patients with normal UACR were further divided into two groups according to the estimated glomerular filtration rate (eGFR): the eGFR low group (<90 ml·min-1·1.73m-2) and the normal eGFR group (≥90 ml·min-1·1.73m-2). Urine RBP and β2-MG levels among the groups were compared. Multiple linear regression analyses were applied to evaluate risk factors of urine RBP and β2-MG. Results: In all patients (n=1 030), urine RBP and β2-MG increased gradually with the increase of UACR across the three groups, the proportions of abnormal urine RBP (>0.7 mg/L) and β2-MG (>370 μg/L) in these groups were 3.8%, 8.5%, 39.0% (P<0.001), and 12.9%, 26.7%, 46.8% (P<0.001), respectively. In the UACR normal group (n=788), 12.2% of the patients were with eGFR<90 ml·min-1·1.73m-2. The proportion of abnormal β2-MG (>370 μg/L) was higher in the eGFR low group than that in the eGFR normal group (29.2% vs. 10.7%, P<0.001). Multivariate linear stepwise regression analyses were performed using natural logarithm of urine RBP or β2-MG as dependent variable, and showed that urine RBP was independently associated with UACR (β=0.0005, P<0.001), serum creatinine (β=0.006, P<0.001) and glycosylated hemoglobin A1c (β=0.050, P=0.001), and β2-MG was independently correlated with UACR (β=0.000 4, P<0.001), serum creatinine (β=0.011, P<0.001), systolic blood pressure (β=0.005, P=0.031) and fasting blood-glucose (β=0.027, P=0.046). Conclusions: Urine RBP and β2-MG are positively associated with high UACR and impaired renal function in T2DM patients, and these changes could occur before UACR and eGFR turned out to be abnormal. It is recommended that urine RBP and β2-MG be detected as early as possible to identify diabetic kidney disease in patients with normal UACR and eGFR.
Collapse
Affiliation(s)
- S M Li
- Departments of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing 100044, China
| | - Y A Wang
- Departments of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing 100044, China
| | - W Liu
- Departments of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing 100044, China
| | - Z Y Wu
- Departments of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing 100044, China
| | - L Chen
- Departments of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing 100044, China
| | - X L Cai
- Departments of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing 100044, China
| | - R Zhang
- Departments of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing 100044, China
| | - W J Yang
- Departments of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing 100044, China
| | - Y Liu
- Departments of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing 100044, China
| | - Y M Ma
- Departments of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing 100044, China
| | - S Q Gong
- Departments of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing 100044, China
| | - S M Zhang
- Departments of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing 100044, China
| | - Q Ren
- Departments of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing 100044, China
| | - X Y Han
- Departments of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing 100044, China
| | - L N Ji
- Departments of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing 100044, China
| |
Collapse
|
212
|
Sun L, Zhang X, Wu S, Liao Y, Zhang X, Liu W, Zhang L. 634 Single cell transcriptomics identifies a two way conversion program between dermal progenitors and adipocytes during skin development and regeneration. J Invest Dermatol 2021. [DOI: 10.1016/j.jid.2021.02.663] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
213
|
Liu W, Zhang GQ, Zhu DY, Wang LJ, Li GT, Xu JG, Jin XL, Zhu YM, Yang XY. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci 2021; 24:7612-7620. [PMID: 32744687 DOI: 10.26355/eurrev_202007_22259] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
OBJECTIVE Long noncoding RNA (lncRNA) is emerging as a vital regulator in various tumors. However, the biological function of ZFPM2-antisense RNA 1 (ZFPM2-AS1) in hepatocellular carcinoma (HCC) remains unclear. The present study aims to explore the function and mechanism of ZFPM2-AS1 in hepatocellular carcinoma progression. PATIENTS AND METHODS The ZFPM2-AS1 expression in HCC cells and tissues was measured by quantitative real-time polymerase chain reaction (qRT-PCR). Effects of ZFPM2-AS1 on tumor cell proliferation and invasion were detected by CCK8 assay or EdU assay or matrigel migration assay and Western blot. The Luciferase reporter assay, RNA pulldown assay, qRT-PCR, and Western blot were performed to explore and confirm the interaction between ZFPM2-AS1 and miR-1226-3p and integrin β1 (ITGB1). RESULTS ZFPM2-AS1 was overexpressed in HCC tissues and cell lines. High levels of ZFPM2-AS1 were correlated with advanced TNM stage, distant metastasis and a poorer overall survival rate. ZFPM2-AS1 knockdown inhibited cell proliferation and invasion. ZFPM2-AS1 could directly bind to and negatively regulate miR-1226-3p expression. Moreover, ITGB1 was identified as a target gene of miR-1226-3p. ITGB1 was found to be directly negatively regulated by miR-1226-3p and indirectly upregulated by ZFPM2-AS1. Rescue assays demonstrated that ZFPM2-AS1 promotes HCC cell proliferation and invasion through modulating miR-1226/ITGB1 axis. CONCLUSIONS ZFPM2-AS1 promotes cell proliferation and migration by regulating miR-1226-3p/ITGB1 axis in HCC.
Collapse
Affiliation(s)
- W Liu
- Department of Infectious Diseases, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, China.
| | | | | | | | | | | | | | | | | |
Collapse
|
214
|
Zhang DL, Xue F, Dou XQ, Liu XF, Fu RF, Chen YF, Liu W, Jia YJ, Wang YH, Xiao ZJ, Zhang L, Yang RC. [Clinical and genetic analyses of hereditary factor Ⅴ deficiency cases]. Zhonghua Xue Ye Xue Za Zhi 2021; 42:302-307. [PMID: 33979974 PMCID: PMC8120128 DOI: 10.3760/cma.j.issn.0253-2727.2021.04.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Indexed: 11/05/2022]
Abstract
Objective: To analyze the clinical phenotype and molecular pathogenesis of nine patients with hereditary factor Ⅴ (FⅤ) deficiency. Methods: Nine patients with hereditary FⅤ deficiency who were admitted to the Institute of Hematology and Blood Diseases Hospital from April 1999 to September 2019 were analyzed. The activated partial thromboplastin time, prothrombin time, and FⅤ procoagulant activity (FⅤ∶C) were measured for phenotypic diagnosis. High-throughput sequencing was employed for the F5 gene mutation screening, Sanger sequencing was adopted to confirm candidate variants and parental carrying status, Swiss-model was used for three-dimensional structure analysis, and ClustalX v.2.1 was used for homologous analysis. Results: The FⅤ∶C of the nine patients ranged from 0.1 to 10.6. Among them, eight had a hemorrhage history, with kin/mucosal bleeding as the most common symptom (three cases, 37.5%) , whereas one case had no bleeding symptom. There were five homozygotes and four compound heterozygotes. A total of 12 pathogenic or likely pathogenic mutations were detected, of which c.6100C>A/p.Pro2034Thr, c.6575T>C/p.Phe2192Ser, c.1600_1601delinsTG/p. Gln534*, c.4713C>A/p.Tyr1571*, and c.952+5G>C were reported for the first time. Conclusion: The newly discovered gene mutations enriched the F5 gene mutation spectrum associated with hereditary FⅤ deficiency. High-throughput sequencing could be an effective method to detect F5 gene mutations.
Collapse
Affiliation(s)
- D L Zhang
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - F Xue
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - X Q Dou
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - X F Liu
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - R F Fu
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - Y F Chen
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - W Liu
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - Y J Jia
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - Y H Wang
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - Z J Xiao
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - L Zhang
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - R C Yang
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| |
Collapse
|
215
|
Amenomori M, Bao YW, Bi XJ, Chen D, Chen TL, Chen WY, Chen X, Chen Y, Cui SW, Ding LK, Fang JH, Fang K, Feng CF, Feng Z, Feng ZY, Gao Q, Gou QB, Guo YQ, Guo YY, He HH, He ZT, Hibino K, Hotta N, Hu H, Hu HB, Huang J, Jia HY, Jiang L, Jin HB, Kasahara K, Katayose Y, Kato C, Kato S, Kawata K, Kihara W, Ko Y, Kozai M, Le GM, Li AF, Li HJ, Li WJ, Lin YH, Liu B, Liu C, Liu JS, Liu MY, Liu W, Lou YQ, Lu H, Meng XR, Munakata K, Nakada H, Nakamura Y, Nanjo H, Nishizawa M, Ohnishi M, Ohura T, Ozawa S, Qian XL, Qu XB, Saito T, Sakata M, Sako TK, Shao J, Shibata M, Shiomi A, Sugimoto H, Takano W, Takita M, Tan YH, Tateyama N, Torii S, Tsuchiya H, Udo S, Wang H, Wu HR, Xue L, Yamamoto Y, Yang Z, Yokoe Y, Yuan AF, Zhai LM, Zhang HM, Zhang JL, Zhang X, Zhang XY, Zhang Y, Zhang Y, Zhang Y, Zhao SP, Zhou XX. First Detection of sub-PeV Diffuse Gamma Rays from the Galactic Disk: Evidence for Ubiquitous Galactic Cosmic Rays beyond PeV Energies. Phys Rev Lett 2021; 126:141101. [PMID: 33891464 DOI: 10.1103/physrevlett.126.141101] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/06/2020] [Revised: 01/05/2021] [Accepted: 01/21/2021] [Indexed: 06/12/2023]
Abstract
We report, for the first time, the long-awaited detection of diffuse gamma rays with energies between 100 TeV and 1 PeV in the Galactic disk. Particularly, all gamma rays above 398 TeV are observed apart from known TeV gamma-ray sources and compatible with expectations from the hadronic emission scenario in which gamma rays originate from the decay of π^{0}'s produced through the interaction of protons with the interstellar medium in the Galaxy. This is strong evidence that cosmic rays are accelerated beyond PeV energies in our Galaxy and spread over the Galactic disk.
Collapse
Affiliation(s)
- M Amenomori
- Department of Physics, Hirosaki University, Hirosaki 036-8561, Japan
| | - Y W Bao
- School of Astronomy and Space Science, Nanjing University, Nanjing 210093, China
| | - X J Bi
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - D Chen
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing 100012, China
| | - T L Chen
- Physics Department of Science School, Tibet University, Lhasa 850000, China
| | - W Y Chen
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - Xu Chen
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - Y Chen
- School of Astronomy and Space Science, Nanjing University, Nanjing 210093, China
| | - S W Cui
- Department of Physics, Hebei Normal University, Shijiazhuang 050016, China
| | - L K Ding
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - J H Fang
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
- University of Chinese Academy of Sciences, Beijing 100049, China
| | - K Fang
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - C F Feng
- Institute of Frontier and Interdisciplinary Science and Key Laboratory of Particle Physics and Particle Irradiation (MOE), Shandong University, Qingdao 266237, China
| | - Zhaoyang Feng
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - Z Y Feng
- Institute of Modern Physics, SouthWest Jiaotong University, Chengdu 610031, China
| | - Qi Gao
- Physics Department of Science School, Tibet University, Lhasa 850000, China
| | - Q B Gou
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - Y Q Guo
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - Y Y Guo
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - H H He
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - Z T He
- Department of Physics, Hebei Normal University, Shijiazhuang 050016, China
| | - K Hibino
- Faculty of Engineering, Kanagawa University, Yokohama 221-8686, Japan
| | - N Hotta
- Faculty of Education, Utsunomiya University, Utsunomiya 321-8505, Japan
| | - Haibing Hu
- Physics Department of Science School, Tibet University, Lhasa 850000, China
| | - H B Hu
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - J Huang
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - H Y Jia
- Institute of Modern Physics, SouthWest Jiaotong University, Chengdu 610031, China
| | - L Jiang
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - H B Jin
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing 100012, China
| | - K Kasahara
- Faculty of Systems Engineering, Shibaura Institute of Technology, Omiya 330-8570, Japan
| | - Y Katayose
- Faculty of Engineering, Yokohama National University, Yokohama 240-8501, Japan
| | - C Kato
- Department of Physics, Shinshu University, Matsumoto 390-8621, Japan
| | - S Kato
- Institute for Cosmic Ray Research, University of Tokyo, Kashiwa 277-8582, Japan
| | - K Kawata
- Institute for Cosmic Ray Research, University of Tokyo, Kashiwa 277-8582, Japan
| | - W Kihara
- Department of Physics, Shinshu University, Matsumoto 390-8621, Japan
| | - Y Ko
- Department of Physics, Shinshu University, Matsumoto 390-8621, Japan
| | - M Kozai
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency (ISAS/JAXA), Sagamihara 252-5210, Japan
| | - G M Le
- National Center for Space Weather, China Meteorological Administration, Beijing 100081, China
| | - A F Li
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
- Institute of Frontier and Interdisciplinary Science and Key Laboratory of Particle Physics and Particle Irradiation (MOE), Shandong University, Qingdao 266237, China
- School of Information Science and Engineering, Shandong Agriculture University, Taian 271018, China
| | - H J Li
- Physics Department of Science School, Tibet University, Lhasa 850000, China
| | - W J Li
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
- Institute of Modern Physics, SouthWest Jiaotong University, Chengdu 610031, China
| | - Y H Lin
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
- University of Chinese Academy of Sciences, Beijing 100049, China
| | - B Liu
- Department of Astronomy, School of Physical Sciences, University of Science and Technology of China, Hefei, Anhui 230026, China
| | - C Liu
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - J S Liu
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - M Y Liu
- Physics Department of Science School, Tibet University, Lhasa 850000, China
| | - W Liu
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - Y-Q Lou
- Department of Physics and Tsinghua Centre for Astrophysics (THCA), Tsinghua University, Beijing 100084, China
- Tsinghua University-National Astronomical Observatories of China (NAOC) Joint Research Center for Astrophysics, Tsinghua University, Beijing 100084, China
- Department of Astronomy, Tsinghua University, Beijing 100084, China
| | - H Lu
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - X R Meng
- Physics Department of Science School, Tibet University, Lhasa 850000, China
| | - K Munakata
- Department of Physics, Shinshu University, Matsumoto 390-8621, Japan
| | - H Nakada
- Faculty of Engineering, Yokohama National University, Yokohama 240-8501, Japan
| | - Y Nakamura
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - H Nanjo
- Department of Physics, Hirosaki University, Hirosaki 036-8561, Japan
| | - M Nishizawa
- National Institute of Informatics, Tokyo 101-8430, Japan
| | - M Ohnishi
- Institute for Cosmic Ray Research, University of Tokyo, Kashiwa 277-8582, Japan
| | - T Ohura
- Faculty of Engineering, Yokohama National University, Yokohama 240-8501, Japan
| | - S Ozawa
- National Institute of Information and Communications Technology, Tokyo 184-8795, Japan
| | - X L Qian
- Department of Mechanical and Electrical Engineering, Shandong Management University, Jinan 250357, China
| | - X B Qu
- College of Science, China University of Petroleum, Qingdao, 266555, China
| | - T Saito
- Tokyo Metropolitan College of Industrial Technology, Tokyo 116-8523, Japan
| | - M Sakata
- Department of Physics, Konan University, Kobe 658-8501, Japan
| | - T K Sako
- Institute for Cosmic Ray Research, University of Tokyo, Kashiwa 277-8582, Japan
| | - J Shao
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
- Institute of Frontier and Interdisciplinary Science and Key Laboratory of Particle Physics and Particle Irradiation (MOE), Shandong University, Qingdao 266237, China
| | - M Shibata
- Faculty of Engineering, Yokohama National University, Yokohama 240-8501, Japan
| | - A Shiomi
- College of Industrial Technology, Nihon University, Narashino 275-8575, Japan
| | - H Sugimoto
- Shonan Institute of Technology, Fujisawa 251-8511, Japan
| | - W Takano
- Faculty of Engineering, Kanagawa University, Yokohama 221-8686, Japan
| | - M Takita
- Institute for Cosmic Ray Research, University of Tokyo, Kashiwa 277-8582, Japan
| | - Y H Tan
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - N Tateyama
- Faculty of Engineering, Kanagawa University, Yokohama 221-8686, Japan
| | - S Torii
- Research Institute for Science and Engineering, Waseda University, Tokyo 169-8555, Japan
| | - H Tsuchiya
- Japan Atomic Energy Agency, Tokai-mura 319-1195, Japan
| | - S Udo
- Faculty of Engineering, Kanagawa University, Yokohama 221-8686, Japan
| | - H Wang
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - H R Wu
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - L Xue
- Institute of Frontier and Interdisciplinary Science and Key Laboratory of Particle Physics and Particle Irradiation (MOE), Shandong University, Qingdao 266237, China
| | - Y Yamamoto
- Department of Physics, Konan University, Kobe 658-8501, Japan
| | - Z Yang
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - Y Yokoe
- Institute for Cosmic Ray Research, University of Tokyo, Kashiwa 277-8582, Japan
| | - A F Yuan
- Physics Department of Science School, Tibet University, Lhasa 850000, China
| | - L M Zhai
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing 100012, China
| | - H M Zhang
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - J L Zhang
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - X Zhang
- School of Astronomy and Space Science, Nanjing University, Nanjing 210093, China
| | - X Y Zhang
- Institute of Frontier and Interdisciplinary Science and Key Laboratory of Particle Physics and Particle Irradiation (MOE), Shandong University, Qingdao 266237, China
| | - Y Zhang
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - Yi Zhang
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, Nanjing 210034, China
| | - Ying Zhang
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - S P Zhao
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - X X Zhou
- Institute of Modern Physics, SouthWest Jiaotong University, Chengdu 610031, China
| |
Collapse
|
216
|
Ravichandran R, Itabashi Y, Liu W, Poulson C, Fleming T, Mohanakumar T. Low Dose Interleukin-2 Induces Exosomes with Tolerance Markers (PDL1, CD73) and Significantly Delays Development of Chronic Rejection Following Murine Heterotopic Cardiac Transplantation. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.1814] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
217
|
Abstract
Nasopharyngeal carcinoma (NPC) is an epithelial cancer associated with Epstein-Barr virus. Despite NPC is a widespread malignancy, little is known about association of tumor growth with gene expression. This study is aimed to detect potential genes implicated in the molecular mechanism of NPC. To this end, we downloaded GSE12452, GSE53819 and GSE64634 libraries from GEO database. GEO2R interface was used to search for the differentially expressed genes (DEGs) with R and LIMMA software, which yielded the Venn diagrams of co-expressed genes. The GO and KEGG databases were used to find DEGs with up- and down-regulated expression. Then Cytoscape software constructed and analyzed the protein-protein interaction (PPI) networks corresponding to revealed DEGs, thereupon the hub genes were analyzed in tissues and cell cultures with qRT-PCR. This combined analysis yielded 483 co-expressed DEGs, including 258 DEGs with up-regulated expression and 225 DEGs with down-regulated expression, which are mainly implicated in the cell cycle, DNA replication, as well as in formation and maturation of extracellular vesicles and exosomes. In comparison with normal nasopharyngeal tissues of healthy persons, expression of CDK1 gene was down-regulated in NPC tissue; in contrast, expression of PCNA, MAD2L1, PRC1, CENPF, and ZWINT genes was up-regulated in the tumor. The genes PCNA, MAD2L1, and ZWINT were differently expressed in EBV+ and EBV- nasopharyngeal carcinoma cells. The use of bioinformatic methods to reveal and analyze the differences in gene expression between the normal and NPC tissues opens the vista to further progress in deciphering the molecular mechanisms of NPC formation and development.
Collapse
Affiliation(s)
- B Wang
- Department of Immunology, Qingdao University Medical College, Qingdao, Shandong, P.R. China
| | - W Wang
- Department of Pathogenic Biology, Qingdao University Medical College, Qingdao, Shandong, P.R. China
| | - H Wang
- Department of Pathogenic Biology, Qingdao University Medical College, Qingdao, Shandong, P.R. China
| | - W Liu
- Department of Pathogenic Biology, Qingdao University Medical College, Qingdao, Shandong, P.R. China.
| |
Collapse
|
218
|
Wang LJ, Wang HW, Jin KM, Liu W, Bao Q, Wang K, Xing BC. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis]. Zhonghua Wei Chang Wai Ke Za Zhi 2021; 24:248-255. [PMID: 34645169 DOI: 10.3760/cma.j.cn.441530-20200606-00346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To compare the survival outcome in patients with synchronous colorectal cancer liver metastasis receiving neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery strategies. Methods: A retrospective cohort study was carried out. Data of patients undergoing surgery at the Department of Hepatopancreatobiliary Surgery Unit I of Peking University Cancer Hospital from January 2008 to December 2018 for initially resectable synchronous colorectal liver metastasis were retrospectively collected. A total of 282 cases were enrolled, including 244 in the neoadjuvant chemotherapy group, 38 in the upfront surgery first group. The overall survival (OS) and progression-free survival (PFS) of the two groups were compared. A propensity score risk adjustment was used to eliminate potential bias between groups, and the covariates including sex, age, location of primary tumor, T stage, clinical risk score (CRS), RAS gene status, adjuvant chemotherapy, and resection margin status were included for adjustment. Results: In the neoadjuvant chemotherapy group, 244 cases received 4 (1-15) cycles of chemotherapy before hepatic resection, among whom 207 cases received oxaliplatin-based regimens, 37 cases received irinotecan-based regimens, and 90 cases received combined targeted agents in the first line treatment. The median follow-up time was 30 (5-134) months, and loss of follow-up was 1%. Before adjustment, Kaplan-Meier survival analysis showed that the 1-year and 3-year OS rates in the neoadjuvant chemotherapy group (95.1% and 66.4%) were better than those in the upfront surgery first group (94.7% and 51.5%, P=0.026); 1-year and 3-year PFS rates in neoadjuvant chemotherapy group (51.0% and 23.4%) were also better than those in surgery first group (39.5% and 11.5%, P=0.039). After propensity score risk adjustment, Cox multivariate analysis indicated that neoadjuvant chemotherapy was an independent protective factor of PFS (HR=0.664, 95% CI: 0.449-0.982, P=0.040), however, neoadjuvant chemotherapy was not an independent protective factor of OS (HR=0.651, 95% CI: 0.393-1.079, P=0.096). Subgroup analysis showed that the 1-year and 3-year OS rates in the patients with response to the first line treatment (194, including complete remission, partial remission and reduction but not partial remission) (96.9% and 67.1%) were better than those in the upfront surgery group (94.7% and 51.5%, P=0.026) after adjustment. However, the 1-year and 3-year OS rates in the patients without response to the first line treatment (50, including tumor progression or enlargement) were 90.0% and 63.3%, respectively, which were not significantly different with 94.7% and 51.5% in the upfront surgery group (P=0.310) after adjustment. Conclusions: For patients with resectable synchronous colorectal cancer liver metastasis, liver resection after neoadjuvant chemotherapy can provide longer PFS than upfront surgery. Although the whole OS benefit is not significant, patients with effective neoadjuvant first-line chemotherapy have better OS than those undergoing upfront surgery.
Collapse
Affiliation(s)
- L J Wang
- Department of Hepatopancreatobiliary Surgery Unit I, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing 100142, China
| | - H W Wang
- Department of Hepatopancreatobiliary Surgery Unit I, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing 100142, China
| | - K M Jin
- Department of Hepatopancreatobiliary Surgery Unit I, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing 100142, China
| | - W Liu
- Department of Hepatopancreatobiliary Surgery Unit I, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing 100142, China
| | - Q Bao
- Department of Hepatopancreatobiliary Surgery Unit I, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing 100142, China
| | - K Wang
- Department of Hepatopancreatobiliary Surgery Unit I, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing 100142, China
| | - B C Xing
- Department of Hepatopancreatobiliary Surgery Unit I, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing 100142, China
| |
Collapse
|
219
|
Gu ZR, Liu W. The LncRNA AL161431.1 targets miR-1252-5p and facilitates cellular proliferation and migration via MAPK signaling in endometrial carcinoma. Eur Rev Med Pharmacol Sci 2021; 24:2294-2302. [PMID: 32196580 DOI: 10.26355/eurrev_202003_20495] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE The aim of this study was to determine the expression profile and the underlying mechanism of the long intergenic non-protein coding RNA AL161431.1 in EC (endometrial carcinoma). MATERIALS AND METHODS In this study, the expression data for the lncRNA AL161431.1 in EC was downloaded from The Cancer Genome Atlas (TCGA) database and used to examine its expression profile. quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blot analysis were used to detect gene and protein expression, respectively. A subcellular fractionation assay was used to determine the location of AL161431.1. Cell Counting Kit-8 (CCK-8) and colony formation assays were used to evaluate cellular proliferation. Cell migration and wound healing assays were used to detect the effects on cell migration. RNA pull-down and Luciferase reporter assays were used to confirm the interaction between AL161431.1 and miR-1252-5p. RESULTS High expression levels of AL161431.1 were observed in EC patients, tissues, and cells. Loss-of-function experiments validated the carcinogenic role of AL161431.1. Based on the determined cytoplasmic location of AL161431.1, we investigated the ceRNA network and its relation to AL161431.1, miR-1252-5p, and MAPK (mitogen-activated protein kinase) signaling in EC. The molecular mechanism of the interaction between AL161431.1 and miR-1252-5p, and its effects on the MAPK signaling pathway was validated using rescue experiments in Ishikawa cells. CONCLUSIONS Our novel results indicate that AL161431.1 targets and binds to miR-1252-5p, resulting in the de-repression of MAPK signaling in EC cells. This highlights the potential for AL161431.1 to be targeted as a potent therapeutic strategy in the treatment of EC.
Collapse
Affiliation(s)
- Z-R Gu
- Department of Obstetrics and Gynecology, the 5th People's Hospital of Ji'nan, Ji'nan, Shandong Province, P.R. China.
| | | |
Collapse
|
220
|
Liu W, Niu F, Sha H, Liu LD, Lv ZS, Gong WQ, Yan M. Apelin-13/APJ system delays intervertebral disc degeneration by activating the PI3K/AKT signaling pathway. Eur Rev Med Pharmacol Sci 2021; 24:2820-2828. [PMID: 32271399 DOI: 10.26355/eurrev_202003_20643] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE To study the effect of Apelin-13/APJ system on intervertebral disc degeneration and its mechanism. PATIENTS AND METHODS This study detected the expression of APJ in human intervertebral disc tissue with varying degrees of degeneration. IL-1β is used to stimulate the degeneration of nucleus pulposus cells. We used recombinant human Apelin-13 and Ala13 to activate and inhibit the APJ receptor, respectively. The inhibitor LY294002 was used to inhibit the PI3K/AKT signaling pathway. We studied the effects of Apelin-13/APJ system on nucleus pulposus cells and its mechanism by Western blot, RT-PCR, and so on. RESULTS APJ is lowly expressed in the nucleus pulposus of patients with a high degree of degeneration. IL-1β stimulates the nucleus pulposus cells and reduces the expression of APJ in nucleus pulposus cells. Recombinant human Apelin-13 reduces the degradation of nucleus pulposus extracellular matrix, promotes proliferation, and reduces the levels of apoptosis and inflammation. In addition, the Apelin-13/APJ system increases the expression of PI3K and AKT and activates the PI3K/AKT signaling pathway. CONCLUSIONS Apelin-13/APJ system activates PI3K/AKT signaling pathway activity, reduces the degradation of nucleus pulposus extracellular matrix, promotes proliferation, and reduces the level of apoptosis and inflammation, thus delaying the degeneration of the intervertebral disc.
Collapse
Affiliation(s)
- W Liu
- Department of Spine Surgery, The First Hospital of Jilin University, Changchun, China.
| | | | | | | | | | | | | |
Collapse
|
221
|
Yan M, Pan XF, Liu Y, Zhao S, Gong WQ, Liu W. Long noncoding RNA PVT1 promotes metastasis via miR-484 sponging in osteosarcoma cells. Eur Rev Med Pharmacol Sci 2021; 24:2229-2238. [PMID: 32196583 DOI: 10.26355/eurrev_202003_20488] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE Long noncoding RNAs (lncRNAs) are widely involved in various malignancies including osteosarcoma. In the current study, we aimed to illustrate the role of lncRNA plasmacytoma variant translocation 1 (PVT1) in osteosarcoma. PATIENTS AND METHODS Expression of PVT1 and microRNA-486 (miR-486) in osteosarcoma tissue specimens and cell lines were detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) assays and in situ hybridizations (ISH) assay. Transwell migration/invasion assays were performed to determine the metastatic ability changes in osteosarcoma cells. Kaplan-Meier survival analysis was applied to analyze the overall survival (OS) of patients with osteosarcoma. Luciferase assays were used to evaluate the targeted binding effect between PVT1 and miR-486. RESULTS We illustrated that lncRNA plasmacytoma variant translocation 1 (PVT1) was upregulated in osteosarcoma, and it was correlated with poor prognosis of patients with osteosarcoma. Furthermore, we found that PVT1, via constructed loss of function and gain of function assays, promoted osteosarcoma cells migration and invasion. Meanwhile, we demonstrated that microRNA-486 (miR-486) was involved in PVT1-induced migration and invasion. We also uncovered that miR-486 was downregulated in osteosarcoma tissue specimens and cell lines. Functionally, we showed that upregulation of miR-486 reversed the facilitative effect of PVT1 on osteosarcoma cells migration and invasion, and vice versa. Mechanically, we illustrated that PVT1 interacted with miR-486 in a reciprocal suppressed manner. Moreover, we found that miR-486 could target to PVT1 via Luciferase assay. Lastly, we proved that PVT1 promoted osteosarcoma cells migration and invasion through miR-486 sponging. CONCLUSIONS We demonstrated that PVT1, functioning as an oncogene, promotes osteosarcoma cells metastasis via miR-486 sponging. PVT1/miR-486 axis might be a novel target in the molecular treatment of osteosarcoma.
Collapse
Affiliation(s)
- M Yan
- Department of Spinal Surgery, The First Hospital of Jilin University, Changchun, P.R. China.
| | | | | | | | | | | |
Collapse
|
222
|
Gong TF, He JL, Tan L, Xie LX, Liu W. [Genetic diversity of Sparganum isolates from snakes in Hunan Province based on mitochondrial nad4 and nad5 genes]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2021; 33:35-39. [PMID: 33660472 DOI: 10.16250/j.32.1374.2020305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE To investigate the genetic diversity and phylogenetic relationship of Sparganum isolates from snakes in Hunan Province. METHODS The partial mitochondrial NADH dehydrogenase subunit 4 (pnad4) and NADH dehydrogenase subunit 5 (pnad5) genes were amplified using a PCR assay in 7 Sparganum isolates from snakes in Hunan Province and the amplification product was sequenced. The homology and genetic evolution were investigated using the software DNAMAN 7.0, MegAlign, DnaSP 5.0 and MEGA 5.0. RESULTS The pnad4 and pnad5 gene sequences were approximately 578 bp and 484 bp in length in the 7 Sparganum isolates from Hunan Province, and the percentages of genetic variations were 0 to 2.8% and 0 to 0.8%, respectively. There were 4 haplotypes detected in both the pnad4 and pnad5 genes, with global haplotype diversities of 0.810 ± 0.016 and 0.905 ± 0.011, nucleotide diversities of 0.006 ± 0.005 and 0.004 ± 0.003, and mean nucleotide variations of 3.960 and 1.905, respectively. Phylogenetic analysis showed that all 7 Sparganum isolates from snakes in Hunan Province were clustered into the same branch with Spirometra erinaceieuropaei isolates from different regions/hosts in the world, which belonged to S. erinaceieuropaei, which were close to Diphyllobothrium latum and far from other tapeworms. CONCLUSIONS There is a low genetic variation in snake-derived S. erinaceieuropaei isolates from Hunan Province, and both pnad4 and pnad5 genes may be potential molecular genetic markers for identification of S. erinaceieuropaei.
Collapse
Affiliation(s)
- T F Gong
- College of Veterinary Medicine, Hunan Agricultural University, Changsha 410128, China
| | - J L He
- College of Veterinary Medicine, Hunan Agricultural University, Changsha 410128, China
| | - L Tan
- College of Veterinary Medicine, Hunan Agricultural University, Changsha 410128, China
| | - L X Xie
- College of Veterinary Medicine, Hunan Agricultural University, Changsha 410128, China
| | - W Liu
- College of Veterinary Medicine, Hunan Agricultural University, Changsha 410128, China
| |
Collapse
|
223
|
Zhang AA, Tang JY, Xu M, Fang YJ, Yan J, Gao J, Yuan XJ, Li F, Ju XL, Liu W, Wu XJ, Sun LR, Jiang L, Zhang WL, Chu JH, Lu XY. [Multicenter clinical study on the diagnosis and treatment of childhood renal tumor]. Zhonghua Er Ke Za Zhi 2021; 59:195-200. [PMID: 33657693 DOI: 10.3760/cma.j.cn112140-20200707-00698] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To summarize the effect of Chinese Children's Cancer Group (CCCG) Wilms tumor (WT)-2015 protocol. Methods: This was a prospective study. CCCG-WT-2015 protocol was revised on the basis of the CCCG-WT-2009 protocol. Clinical data of 288 children diagnosed with newly diagnosed kidney neoplasms in fourteen pediatric centers between September 2015 to December 2018 were summarized. The age of onset, distribution of pathological subtypes, staging, curative effect and prognostic factors of these children were analyzed. Kaplan-Meier method was used for survival curve and Log-Rank method was used for univariate analysis. Results: Among 288 cases with kidney neoplasms, there were 261 cases of WT, including 254 cases (97.3%) with favorable histology (FH) WT and 7 cases (2.7%) with unfavorable histology WT (UFHWT). The 3 year events free survival (EFS) rate for FHWT and UFHWT were (88.9±2.1)% and (80.0±17.9)%, which were better than that in WT-2009 (81.2% and 71.7%). In the 96 cases of stage Ⅲ/Ⅳ FHWT with indications for radiotherapy, 76 cases received radiation, another 20 cases received M protocol chemotherapy (cyclophosphamide, etoposide, gentamycin, vincristine and adriamycin) instead of radiation. The 3 year EFS rate for these two groups were (84.7±4.3)% and (84.7±8.1)%(χ2=0.015, P=0.902). There were 22 renal clear cell sarcoma and 5 malignant rhabdoid tumor, 3 year EFS rate of them was (94.4±5.4)% and (20.0±17.9)%. Univariate analysis was performed for age, gender, pathological type, stage, whether rupture occurred during operation, whether complete remission (CR) occurred at the end of treatment and radiotherapy. Pathological types (χ2=44.329,P<0.01) and failure to achieve CR at the end of the treatment (χ2=49.459,P<0.01) were independent factor for predicting survival. Conclusion: Compared with CCCG-WT-2009, treatment of renal tumors in CCCG-WT-2015 study yielded good survival outcome, which can be further applied.
Collapse
Affiliation(s)
- A A Zhang
- Department of Hematology and Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
| | - J Y Tang
- Department of Hematology and Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
| | - M Xu
- Department of Oncology Surgery, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
| | - Y J Fang
- Department of Hematology and Oncology, Children's Hospital of Nanjing Medical University,Nanjing 210008, China
| | - J Yan
- Department of Oncology, Tianjin Medical University Cancer Hospital,Tianjin 300020, China
| | - J Gao
- Department of Hematology and Oncology, West China Second University Hospital, Sichuan University, Chengdu 610041, China
| | - X J Yuan
- Department of Pediatric Hematology and Oncology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
| | - F Li
- Department of Hematology and Oncology, Qilu Children's Hospital of Shandong University, Jinan 250022, China
| | - X L Ju
- Department of Pediatrics, Qilu Hospital of Shandong University, Jinan 250012, China
| | - W Liu
- Department of Hematology and Oncology, Henan Children's Hospital,Zhengzhou 450018, China
| | - X J Wu
- Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430032, China
| | - L R Sun
- Department of Pediatrics, the Affiliated Hospital of Qingdao University, Qingdao 266555, China
| | - L Jiang
- Department of Pediatrics, the Fourth Hospital of Hebei Medical University,Shijiazhuang 050000, China
| | - W L Zhang
- Department of Pediatric Hematology and Oncology,the Affiliated Hospital of Zhengzhou University, Zhengzhou 450008, China
| | - J H Chu
- Department of Pediatrics, the Second Hospital of Anhui Medical University,Hefei 230601, China
| | - X Y Lu
- Department of Oncology Surgery, Children's Hospital of Anhui Medical University, Hefei 230022, China
| |
Collapse
|
224
|
Liu W, Yuan Y, Koropeckyj-Cox L. Effectiveness of Nutrient Management on Water Quality Improvement: A Synthesis on Nitrate-Nitrogen Loss from Subsurface Drainage. Trans ASABE 2021; 64:675-689. [PMID: 34336367 PMCID: PMC8318126 DOI: 10.13031/trans.14078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Nutrient management, as described in NRCS Code 590, has been intensively investigated, with research largely focused on crop yields and water quality. Yet, due to complex processes and mechanisms in nutrient cycling (especially the nitrogen (N) cycle), there are many challenges in evaluating the effectiveness of nutrient management practices across site conditions. We therefore synthesized data from peer-reviewed publications on subsurface-drained agricultural fields in the Midwest U.S. with corn yield and drainage nitrate-N (NO3-N) export data published from 1980 to 2019. Through literature screening and data extraction from 43 publications, we obtained 577 site-years of data with detailed information on fertilization, corn yields, precipitation, drainage volume, and drainage NO3-N load/concentration or both. In addition, we estimated flow-weighted NO3-N concentrations ([NO3-N]) in drainage for those site-years where only load and volume were reported. Furthermore, we conducted a cost analysis using synthesized and surveyed corn yield data to evaluate the cost-effectiveness of different nutrient management plans. Results from the synthesis showed that N fertilizer rate was strongly positively correlated with corn yields, NO3-N loads, and flow-weighted [NO3-N]. Reducing N fertilizer rates can effectively mitigate NO3-N losses from agricultural fields; however, our cost analysis showed negative economic returns for continuous corn production at lower N rates. In addition, organic fertilizers significantly boosted corn yields and NO3-N losses compared to inorganic fertilizers at comparable rates; however, accurate quantification of plant-available N in organic fertilizers is necessary to guide appropriate nutrient management plans because the nutrient content may be highly variable. In terms of fertilizer application methods, we did not find significant differences in NO3-N export in drainage discharge. Lastly, impact of fertilization timing on NO3-N export varied depending on other factors such as fertilizer rate, source, and weather. According to these results, we suggest that further efforts are still required to produce effective local nutrient management plans. Furthermore, government agencies such as USDA-NRCS need to work with other agencies such as USEPA to address the potential economic losses due to implementation of lower fertilizer rates for water quality improvement.
Collapse
Affiliation(s)
- W Liu
- USEPA Office of Research and Development, Research Triangle Park, North Carolina
| | - Y Yuan
- USEPA Office of Research and Development, Research Triangle Park, North Carolina
| | - L Koropeckyj-Cox
- USEPA Office of Research and Development, Research Triangle Park, North Carolina
| |
Collapse
|
225
|
Zheng L, Zhang M, Zhuo Z, Wang Y, Gao X, Li Y, Liu W, Zhang W. Transcriptome profiling analysis reveals distinct resistance response of cucumber leaves infected with powdery mildew. Plant Biol (Stuttg) 2021; 23:327-340. [PMID: 33176053 DOI: 10.1111/plb.13213] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/07/2020] [Accepted: 10/26/2020] [Indexed: 06/11/2023]
Abstract
Powdery mildew is the main disease affecting cucumber cultivation and causes severe economic loss. So far, research on cucumber resistance to powdery mildew has not yielded feasible solutions. This study selected two inbred cucumber lines, XY09-118 (resistant) and Q10 (susceptible) and investigated their responses to powdery mildew infection (harvested 24 and 48 h after inoculation) using RNA sequencing. More than 20,000 genes were detected in cucumber leaves both with and without powdery mildew infection at the above two time points. Among these, 5478 genes were identified as differently expressed genes (DEGs) between XY09-118 and Q10. Based on the databases GO and KEGG, the functions of DEGs were analysed. Moreover, the complex regulatory network for powdery mildew resistance was assessed, which involves plant hormone signal transduction, phenylpropanoid biosynthesis, plant-pathogen interaction and the MAPK signalling pathway. In particular, genes encoding WRKY, NAC and TCP were highlighted. In addition, genes involved in plant hormone biosynthesis, metabolism and signal transduction, pathogen resistance and abiotic stress response were analysed. Co-expression analysis indicated that the transcription factors correlated with plant hormone signal pathway and metabolism, defence and abiotic response. The expression of several genes was validated by qRT-PCR. The pathogen resistance regulatory network was identified by comparing resistant and susceptible inbred lines infected with powdery mildew. The transcriptome data provide novel insights into cucumber response to powdery mildew infection and the identified pathogen resistance genes will be highly useful for breeding efforts to enhance the resistance of cucumber to powdery mildew.
Collapse
Affiliation(s)
- L Zheng
- Shandong Key Laboratory of Greenhouse Vegetable Biology, Shandong Branch of National Vegetable Improvement Center, Shandong Academy of Agricultural Sciences, Institute of Vegetables and Flowers, Jinan, China
- College of Life and Environment Sciences, Huanshan University, Huangshan, China
| | - M Zhang
- Shandong Key Laboratory of Greenhouse Vegetable Biology, Shandong Branch of National Vegetable Improvement Center, Shandong Academy of Agricultural Sciences, Institute of Vegetables and Flowers, Jinan, China
| | - Z Zhuo
- College of Forestry, Hainan University, Haikou, China
| | - Y Wang
- Shandong Key Laboratory of Greenhouse Vegetable Biology, Shandong Branch of National Vegetable Improvement Center, Shandong Academy of Agricultural Sciences, Institute of Vegetables and Flowers, Jinan, China
| | - X Gao
- Shandong Key Laboratory of Greenhouse Vegetable Biology, Shandong Branch of National Vegetable Improvement Center, Shandong Academy of Agricultural Sciences, Institute of Vegetables and Flowers, Jinan, China
| | - Y Li
- Shandong Key Laboratory of Greenhouse Vegetable Biology, Shandong Branch of National Vegetable Improvement Center, Shandong Academy of Agricultural Sciences, Institute of Vegetables and Flowers, Jinan, China
| | - W Liu
- College of Agricultural Sciences and Technology, Shandong Agriculture and Engineering University, Jinan, China
| | - W Zhang
- Shandong Key Laboratory of Greenhouse Vegetable Biology, Shandong Branch of National Vegetable Improvement Center, Shandong Academy of Agricultural Sciences, Institute of Vegetables and Flowers, Jinan, China
| |
Collapse
|
226
|
Gao GC, Yang DW, Liu W. LncRNA TERC alleviates the progression of osteoporosis by absorbing miRNA-217 to upregulate RUNX2. Eur Rev Med Pharmacol Sci 2021; 24:526-534. [PMID: 32016954 DOI: 10.26355/eurrev_202001_20029] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE To elucidate the role of telomerase RNA elements (TERC) in alleviating osteoporosis (OP) by absorbing microRNA-217 (miRNAs-217) to regulate runt-related transcription factor 2 (RUNX2) level. MATERIALS AND METHODS The serum levels of TERC and miRNA-217 in OP patients and healthy controls were determined. During the osteogenic process, the relative levels of alkaline phosphatase (ALP), RUNX2, and Osterix were determined in hMSCs. The regulatory effects of TERC, miRNA-217, and RUNX2 on ALP and RUNX2 levels in hMSCs were examined by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blot. In addition, the changes in ALP activity and calcification ability in hMSCs influenced by them were assessed through ALP activity determination and alizarin red staining, respectively. The interaction of TERC/miRNA-217/RUNX2 regulatory loop and its role in influencing hMSCs osteogenesis were assessed by Dual-Luciferase Reporter Gene Assay and a series of rescue experiments, respectively. RESULTS The downregulated TERC and upregulated miRNA-217 were identified in the serum of the OP patients. Consistently, the downregulated TERC and upregulated miRNA-217 were discovered in in vitro osteogenic process of hMSCs. The silence of TERC, or RUNX2 downregulated ALP and RUNX2 levels, decreased ALP activity and attenuated the calcification ability in hMSCs. The overexpression of miRNA-217 gave similar results. The binding relationship in TERC/miRNA-217/RUNX2 regulatory loop was verified. At last, rescue experiments suggested that TERC accelerated hMSCs osteogenesis by absorbing miRNA-217 to upregulate RUNX2. CONCLUSIONS The serum level of TERC is lowly expressed in OP patients. TERC influences hMSCs osteogenesis by absorbing miRNA-217 to upregulate RUNX2, thus alleviating the progression of OP.
Collapse
Affiliation(s)
- G-C Gao
- Department of Orthopaedics, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
| | | | | |
Collapse
|
227
|
Chen Y, Qian W, Liu W, Zhu Y, Zhou X, Xu Y, Zhu X. Feasibility of single-shot compressed sensing cine imaging for analysis of left ventricular function and strain in cardiac MRI. Clin Radiol 2021; 76:471.e1-471.e7. [PMID: 33563412 DOI: 10.1016/j.crad.2020.12.024] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2020] [Accepted: 12/24/2020] [Indexed: 10/22/2022]
Abstract
AIM To compare single-shot compressed sensing (CS) cine imaging with conventional segmented cine imaging for reliable quantification of left ventricular (LV) volume and strain assessment during cardiac magnetic resonance imaging (CMRI). MATERIALS AND METHODS Thirty-seven participants underwent both single-shot CS and conventional segmented cines that covered the entire LV. LV volumetric and strain values were obtained. LV volumes, global strain, the standard deviation of time to peak strain (SD-TPS) in the radial, longitudinal, and circumferential directions were compared using the Student's t-test and intraclass correlation coefficient (ICC). Interobserver and intra-observer variabilities of the LV strain values for the two cines method were determined using ICC. RESULTS Single-shot CS cine-derived LV volumes and myocardial mass measurements correlated strongly with segmented cines (ICC >0.798) and minor systematic end-systolic volume overestimations resulting in ejection fraction underestimations. Single-shot CS cine-derived global strain and SD-TPS were poorly to moderately correlated with segmented cines (ICC from 0.045-0.706). All global strain values derived from single-shot CS cines were underestimated compared with segmented cine-derived values; however, no significant differences in radial and longitudinal SD-TPS between the two cines were found. Among the patient-related factors, heart rate was a strong predictive factor of global longitudinal strain underestimations (p=0.039) in the CS cines. Inter- and intra-observer LV strain variabilities derived from CS and segmented cines were good to excellent. CONCLUSION Single-shot CS cine CMRI is feasible for the quantitative assessment of LV function. Currently, strain values derived from the two techniques are not interchangeable.
Collapse
Affiliation(s)
- Y Chen
- Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No 300, Guangzhou Road, Nanjing, Jiangsu, 210029, China
| | - W Qian
- Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No 300, Guangzhou Road, Nanjing, Jiangsu, 210029, China
| | - W Liu
- Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No 300, Guangzhou Road, Nanjing, Jiangsu, 210029, China
| | - Y Zhu
- Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No 300, Guangzhou Road, Nanjing, Jiangsu, 210029, China
| | - X Zhou
- MR Collaboration, Siemens Healthineers, Shanghai, China
| | - Y Xu
- Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No 300, Guangzhou Road, Nanjing, Jiangsu, 210029, China.
| | - X Zhu
- Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No 300, Guangzhou Road, Nanjing, Jiangsu, 210029, China.
| |
Collapse
|
228
|
Wang X, Li C, He TQ, Zheng WH, Liu W, Zhang YY, Chen XL, Zhou YQ, Shui CY, Ning YD, Cai YC, Jiang J, Sun RH, Wang W. [Repair of mandibular defects with free iliac musculocutaneous flap assisted by digital and 3D printing technology: a case report]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2021; 56:89-92. [PMID: 33472310 DOI: 10.3760/cma.j.cn115330-20200617-00508] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- X Wang
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Institute of Cancer Research, Sichuan Cancer Prevention and Control Center, Cancer Hospital affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China Department of Clinical Medicine, Chengdu Medical College, Chengdou, 610041, China
| | - C Li
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Institute of Cancer Research, Sichuan Cancer Prevention and Control Center, Cancer Hospital affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China
| | - T Q He
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Institute of Cancer Research, Sichuan Cancer Prevention and Control Center, Cancer Hospital affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China Department of Clinical Medicine, Chengdu Medical College, Chengdou, 610041, China
| | - W H Zheng
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Institute of Cancer Research, Sichuan Cancer Prevention and Control Center, Cancer Hospital affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan Province, China
| | - W Liu
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Institute of Cancer Research, Sichuan Cancer Prevention and Control Center, Cancer Hospital affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China Department of Clinical Medicine, Chengdu Medical College, Chengdou, 610041, China
| | - Y Y Zhang
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Institute of Cancer Research, Sichuan Cancer Prevention and Control Center, Cancer Hospital affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China Department of Clinical Medicine, Chengdu Medical College, Chengdou, 610041, China
| | - X L Chen
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Institute of Cancer Research, Sichuan Cancer Prevention and Control Center, Cancer Hospital affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan Province, China
| | - Y Q Zhou
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Institute of Cancer Research, Sichuan Cancer Prevention and Control Center, Cancer Hospital affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China
| | - C Y Shui
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Institute of Cancer Research, Sichuan Cancer Prevention and Control Center, Cancer Hospital affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China
| | - Y D Ning
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Institute of Cancer Research, Sichuan Cancer Prevention and Control Center, Cancer Hospital affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China
| | - Y C Cai
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Institute of Cancer Research, Sichuan Cancer Prevention and Control Center, Cancer Hospital affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China
| | - J Jiang
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Institute of Cancer Research, Sichuan Cancer Prevention and Control Center, Cancer Hospital affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China
| | - R H Sun
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Institute of Cancer Research, Sichuan Cancer Prevention and Control Center, Cancer Hospital affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China
| | - W Wang
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Institute of Cancer Research, Sichuan Cancer Prevention and Control Center, Cancer Hospital affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China
| |
Collapse
|
229
|
Cao JJ, Zhao SJ, Gao CY, Liu W, Cai HX, Ma PZ. [Association between healthy lifestyle and risk of rehospitalization in male or female patients with chronic heart failure]. Zhonghua Xin Xue Guan Bing Za Zhi 2021; 49:54-59. [PMID: 33429487 DOI: 10.3760/cma.j.cn112148-20201127-00940] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the association between healthy lifestyle and risk of rehospitalization in male or female patients with chronic heart failure (CHF). Methods: Discharged patients with CHF of Henan Provincial People's Hospital Collaboration Hospital were recruited in our study from January 1,2017 to December 31, 2018. The basic information of patients were collected through the electronic medical record system,the questionnaires were used to collect the related influencing factors. Healthy lifestyle includes 4 items, namely non-smoking, moderate exercise, healthy body mass index (BMI) and reasonable diet.Multivariate logistic regression was used to analyze the association between healthy lifestyle and the risk of rehospitalization of CHF patients of different genders. Results: A total of 2 697 patients with CHF were enrolled in this study, including 1 308 male patients(621 rehospitalizations,687 controls)and 1 389 female patients(684 rehospitalizations,705 controls).Among male patients, there was no significant difference in age, residence, marital status, education level, average monthly income, and medical insurance between the rehospitalization group and the control group (all P>0.05). Among female patients, there was no significant difference in age, residence, marital status, education level, average monthly income, and medical insurance between the rehospitalization group and the control group (all P>0.05). Whether in male or female patients with CHF, we found that patients with 4 healthy lifestyles were associated with reduced risk of rehospitalization: male patients OR=0.34, 95%CI 0.11-0.99, P=0.002,female patients OR=0.27, 95%CI 0.13-0.79, P=0.012. A combination of non-smoking and any other 2 healthy lifestyles was associated with reduced risk of rehospitalization: male patients with no smoking, moderate exercise, healthy BMI, OR=0.32, 95%CI 0.11-0.99, P=0.043; female patients OR=0.28, 95%CI 0.12-0.93, P=0.032;male patients with no smoking, moderate exercise, reasonable diet OR=0.42, 95%CI 0.24-0.98, P=0.044,female patients OR=0.40, 95%CI 0.12-0.94, P=0.031;male patients with no smoking, healthy BMI, reasonable diet OR=0.31, 95%CI 0.21-0.92, P=0.039,female patients OR=0.27,95%CI 0.11-0.87, P=0.014. In female patients with CHF, the combination of non-smoking and moderate sports was associated with reduced risk of hospitalization (OR=0.23, 95%CI 0.19-0.97, P=0.038), while no similar results were seen in male patients (OR=0.65, 95%CI 0.33-1.84, P=0.315). Conclusion: Healthy lifestyle is associated with reduced risk of rehospitalization in patients with CHF, and the related healthy lifestyle and its combination may differ between male and female patients.
Collapse
Affiliation(s)
- J J Cao
- Department of Pharmacy,Henan Provincial People's Hospital, Department of Pharmacy,Zhengzhou University People's Hospital, Zhengzhou 450003,China
| | - S J Zhao
- Department of Pharmacy,Henan Provincial People's Hospital, Department of Pharmacy,Zhengzhou University People's Hospital, Zhengzhou 450003,China
| | - C Y Gao
- Department of Coronary Heart Disease, Fuwai Centeral China Cardiovascular Hospital,Zhengzhou 451464,China
| | - W Liu
- School of Pharmacy,Zhengzhou University, Zhengzhou 450001,China
| | - H X Cai
- Department of Pharmacy,Henan Provincial People's Hospital, Department of Pharmacy,Zhengzhou University People's Hospital, Zhengzhou 450003,China
| | - P Z Ma
- Department of Pharmacy,Henan Provincial People's Hospital, Department of Pharmacy,Zhengzhou University People's Hospital, Zhengzhou 450003,China
| |
Collapse
|
230
|
Liu W. Single Molecular Resolution to Monitor DNA Replication Fork Dynamics upon Stress by DNA Fiber Assay. Bio Protoc 2021; 11:e4269. [DOI: 10.21769/bioprotoc.4269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2021] [Revised: 10/11/2021] [Accepted: 10/14/2021] [Indexed: 11/02/2022] Open
|
231
|
Wang Q, Pan Y, Zhao B, Qiao L, Liu J, Liang Y, Liu W. MiR-33a inhibits the adipogenic differentiation of ovine adipose-derived stromal vascular fraction cells by targeting SIRT6. Domest Anim Endocrinol 2021; 74:106513. [PMID: 32653737 DOI: 10.1016/j.domaniend.2020.106513] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/16/2019] [Revised: 03/21/2020] [Accepted: 06/13/2020] [Indexed: 11/18/2022]
Abstract
Adipose tissue is important for the regulation of energy balance through its metabolic, cellular, and endocrine functions. Furthermore, the excessive storage of subcutaneous fat can seriously affect the health and carcass traits of domestic animals. Stromal vascular fraction (SVF) cell adipogenic differentiation increases the number of differentiated adipocytes and plays a role in lipid deposition. The adipogenic differentiation of SVF cells is regulated by various factors, including microRNAs and cytokines. Sirt6 and miR-33a are known to be involved in metabolism and adipogenesis, respectively; however, their effects on the adipogenic differentiation of ovine SVF cells were previously unknown. Thus, the aim of this study was to investigate this. The results showed that SIRT6 is a binding target for miR-33a. Moreover, overexpression or inhibition of miR-33a was found to change the expression of SIRT6 messenger RNA and protein. Furthermore, modulating SIRT6 altered the expression of adipogenic marker genes. In addition, miR-33a and SIRT6 were found to play opposing roles in adipogenesis. Specifically, we demonstrated that miR-33a is involved in the negative regulation of ovine SVF cell adipogenic differentiation by inhibiting the expression of SIRT6. These findings reveal a key role for miR-33a and SIRT6 in adipogenesis, which will enrich our understanding of the regulatory factors associated with SVF cell adipogenic differentiation and provide a basis for further study on this process.
Collapse
Affiliation(s)
- Q Wang
- Department of Animal Genetics, Breeding and Reproduction, College of Animal Science and Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi 030801, China
| | - Y Pan
- Department of Animal Genetics, Breeding and Reproduction, College of Animal Science and Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi 030801, China
| | - B Zhao
- Department of Animal Genetics, Breeding and Reproduction, College of Animal Science and Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi 030801, China
| | - L Qiao
- Department of Animal Genetics, Breeding and Reproduction, College of Animal Science and Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi 030801, China
| | - J Liu
- Department of Animal Genetics, Breeding and Reproduction, College of Animal Science and Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi 030801, China
| | - Y Liang
- Department of Animal Genetics, Breeding and Reproduction, College of Animal Science and Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi 030801, China
| | - W Liu
- Department of Animal Genetics, Breeding and Reproduction, College of Animal Science and Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi 030801, China.
| |
Collapse
|
232
|
Liu W, Zhu X, Tan X, Yang L, Wang Y, Diao S, Huang S, Zhang X, Yang Y, Ni J. Predictive Value of Serum Creatinine/Cystatin C in Acute Ischemic Stroke Patients under Nutritional Intervention. J Nutr Health Aging 2021; 25:335-339. [PMID: 33575725 DOI: 10.1007/s12603-020-1495-0] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
BACKGROUND AND PURPOSE As a very common risk of adverse outcomes of the ischemic stroke patients, sarcopenia is associated with infectious complications and higher mortality. The goal of this retrospective study is to explore the predictive value of serum Cr/CysC ratio in acute ischemic stroke patients receiving nutritional intervention. METHODS We reviewed adult patients with AIS from December 2019 to February 2020. Patients with acute kidney injury were excluded and all patients received nutritional intervention during a 3-month follow-up period. We collected baseline data at admission including creatinine and cystatin C. The primary poor outcome was major disability (modified Rankin Scale score ≥ 4) at 3 months after AIS. RESULTS A total of 217 patients with AIS were identified for this study. Serum Cr/CysC ratio was significantly correlated with NIHSS at discharge, 1-month modified Rankin Scale score, and 3-month modified Rankin Scale score. During 3 months, 34 (15.70%) patients had a poor outcome after AIS and 11 (5.10%) patients died within 30 days. In multivariable logistic regression analyses, serum Cr/CysC ratio at admission was independently associated with 3-month poor outcomes (OR: 0.953, 95% CI: 0.921-0.986, p = .006) and 30-day mortality (OR: 0.953, 95% CI: 0.921-0.986, p = .006). CONCLUSION As a blood biochemical indexes reflecting the muscle mass and aiding in risk stratification, Cr/CysC ratio at admission could be used as a predictor of 30-day mortality and long-term poor prognosis in AIS patients.
Collapse
Affiliation(s)
- W Liu
- Yi Yang MD, Departments of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215000, China, E-mail: , phone: 86-516-67780327
| | | | | | | | | | | | | | | | | | | |
Collapse
|
233
|
Jiao CM, Zhang YL, Dong HX, Chen WJ, Liu W, Li SX, Chen XL. Novel phenolic resin hollow microspheres: Flame retardancy and toxicity reduction in thermoplastic polyurethane elastomer. EXPRESS POLYM LETT 2021. [DOI: 10.3144/expresspolymlett.2021.71] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
234
|
Zhang S, Hu B, Liu W, Wang P, Lv X, Chen S, Shao Z. The role of structure and function changes of sensory nervous system in intervertebral disc-related low back pain. Osteoarthritis Cartilage 2021; 29:17-27. [PMID: 33007412 DOI: 10.1016/j.joca.2020.09.002] [Citation(s) in RCA: 46] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/14/2020] [Revised: 08/18/2020] [Accepted: 09/21/2020] [Indexed: 02/06/2023]
Abstract
Low back pain (LBP) is a common musculoskeletal symptom, which can be developed in multiple clinical diseases. It is widely recognized that intervertebral disc (IVD) degeneration (IVDD) is one of the leading causes of LBP. However, the pathogenesis of IVD-related LBP is still controversial, and the treatment means are also insufficient to date. In recent decades, the role of structure and function changes of sensory nervous system in the induction and the maintenance of LBP is drawing more and more attention. With the progress of IVDD, IVD cell exhaustion and extracellular matrix degradation result in IVD structural damage, while neovascularization, innervation and inflammatory activation further deteriorate the microenvironment of IVD. New nerve ingrowth into degenerated IVD amplifies the impacts of IVD-derived nociceptive molecules on sensory endings. Moreover, IVDD is usually accompanied with disc herniation, which could injure and inflame affected nerves. Under mechanical and pro-inflammatory stimulation, the pain-transmitting pathway exhibits a sensitized function state and ultimately leads to LBP. Hence, relevant pathogenic factors, such as neurotrophins, ion channels, inflammatory factors, etc., are supposed to serve as promising therapeutic targets for LBP. The purpose of this review is to comprehensively summarize the current evidence on 1) the pathological changes of sensory nervous system during IVDD and their association with LBP, and 2) potential therapeutic strategies for LBP targeting relevant pathogenic factors.
Collapse
Affiliation(s)
- S Zhang
- Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
| | - B Hu
- Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
| | - W Liu
- Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
| | - P Wang
- Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
| | - X Lv
- Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
| | - S Chen
- Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
| | - Z Shao
- Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
| |
Collapse
|
235
|
Xiao X, Ai R, Tian Y, Mi N, Liu W, Cheng S, Qian N, Zhu X. Study on the Mechanism of Action of MicroRNA-140-5p in the Treatment of Autism by Regulating the Nuclear Factor Kappa B Signaling Pathway. Indian J Pharm Sci 2021. [DOI: 10.36468/pharmaceutical-sciences.spl.343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
236
|
Guo XY, Liu QL, Liu W, Cheng JX, Li ZJ. Effect and mechanism of miR-135a-5p/CXCL12/JAK-STAT axis on inflammatory response after myocardial infarction. Eur Rev Med Pharmacol Sci 2020; 24:12912-12928. [PMID: 33378042 DOI: 10.26355/eurrev_202012_24195] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE To investigate the regulatory role of miR-135a-5p/CXCL12/JAK-STAT signaling axis in inflammatory response after myocardial infarction (MI). MATERIALS AND METHODS With the construction of mouse model with MI by ligation of left descending coronary artery, modeling mice were subdivided into sh-NC group, sh-CXCL12 group, agomir-NC group, miR-135a-5p agomir group and miR-135a-5p-agomir+pcDNA-CXCL12 with intravenous injection of corresponding adenovirus, and no modeling was made for mice in the sham operation group. Simulation of MI in vivo was realized by hypoxia model in vitro, with the establishment of groups including mimic-NC group, miR-135a-5p mimic group, inhibitor-NC group, miR-135a-5p inhibitor group, sh-NC group, sh-CXCL12 group, oe-NC group, oe-CXCL12 group, mimic NC+oe-NC group, miR-135a-5p mimic+oe-NC group, and miR-135a-5p mimic+oe-CXCL12 group. Real-time quantitative polymerase chain reaction (qRT-PCR) was used to detect the level of miR-135a-5p, CXCL12, TNF-α, IL-1β and IL-6, and Western blot were further performed to detect the mRNA and protein expression of JAK2/p-JAK2 and STAT3/p-STAT3, respectively. Hematoxylin-eosin (HE) staining and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay were used to evaluate MI in mice. Dual-Luciferase reporter assay was used to verify the targeting relationship between miR-135a-5p and CXCL12. Annexin V-fluorescein isothiocyanate/propidium iodide (V-FITC/PI) double staining analysis by flow cytometry was used to detect apoptosis. RESULTS After hypoxia of myocardial cell line H9c2 for 24 h, there were increased expression of CXCL12, decreased expression of miR-135a-5p, increased number of apoptotic cells, as well as upregulated levels of TNF-α, IL-1β and IL-6 (all p<0.05). Meanwhile, similar results were found in the myocardial tissues. Dual-Luciferase reporter assay indicated that miR-135a-5p could target the expression of CXCL12. Transfection of miR-135a-5p mimic or sh-CXCL12 could reduce the number of apoptotic myocardial cells and inhibit the level of TNF-α, IL-1β and IL-6 (all p<0.05). Furthermore, miR-135a-5p mimic or sh-CXCL12 could result in the suppressed expression of p-JAK2 and p-STAT3 (all p<0.05). Compared with miR-135a-5p mimic +DMSO group, the expression of JAK2 and STAT3 in miR-135a-5p mimic +RO8191 group had no significant change (p>0.05); the expression of p-JAK2 and p-STAT3 was increased (all p<0.05), suggesting that miR-135a-5p negatively regulated the expression of CXCL12 and inhibited the activation of JAK-STAT signaling pathway. In addition, for further verification, experiments carried out in sh-NC group, sh-CXCL12 group, agomir-NC group and miR-135a-5p agomir group found that sh-CXCL12 and miR-135a-5p agomir resulted in decreased area of MI decreased, the number of apoptotic cells, the expression of p-JAK2 and p-STAT3 (all p<0.05); while compared with miR-135a-5p-agomir group, miR-135a-5p-agomir+pcDNA-CXCL12 group showed increased area of MI decreased, the number of apoptotic cells, the expression of p-JAK2 and p-STAT3 (all p<0.05). CONCLUSIONS Inhibition of miR-135a-5p/CXCL12/JAK-STAT signaling axis can reduce inflammatory reaction and apoptosis after MI, and hence contribute to the improvement of the degree of myocardial injury.
Collapse
Affiliation(s)
- X-Y Guo
- Department of Cardiology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan Province, P.R. China.
| | | | | | | | | |
Collapse
|
237
|
Zhao ZY, Zhao YC, Liu W. Long non-coding RNA TUG1 regulates the progression and metastasis of osteosarcoma cells via miR-140-5p/PFN2 axis. Eur Rev Med Pharmacol Sci 2020; 23:9781-9792. [PMID: 31799645 DOI: 10.26355/eurrev_201911_19541] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE Osteosarcoma (OS) is a frequently occurred tumor. Recently, increasing reports disclosed that long non-coding RNA taurine upregulated gene 1 (TUG1) was associated with OS development. Nevertheless, the precise regulatory pattern was not completely understood. Hence, we aimed to investigate the biological role of TUG1 in OS tumorigenesis. PATIENTS AND METHODS The levels of TUG1, microRNA-140-5p (miR-140-5p), and Profilin 2 (PFN2) were measured via quantitative Real Time-Polymerase Chain Reaction (qRT-PCR), and the protein level of PNF2 was assessed using Western blot. In addition, MTT assay was employed to detect the ability of cell proliferation in MG63 and U2OS cells. Cell migration and invasion were estimated adopting transwell assay. Moreover, the Dual-Luciferase reporter assay was performed to verify the interrelation between miR-140-5p and TUG1 or PFN2. RESULTS TUG1 and PFN2 levels were evidently upregulated in OS tissues and cell lines. The knockdown of either TUG1 or PFN2 could restrain cell proliferation, migration, and invasion in OS cells. In addition, miR-140-5p was a target of TUG1 to regulate PFN2. The functions of PFN2 knockdown in cell behaviors were rescued after co-transfection with either miR-140-5p inhibitor or overexpression vector of TUG1. Importantly, TUG1 silencing could impede tumor progression in vivo. CONCLUSIONS TUG1 modulated cell proliferation, migration, and invasion via miR-140-5p/PFN2 axis in OS progression, which might trigger the development of therapeutic strategies for the treatment of OS.
Collapse
Affiliation(s)
- Z-Y Zhao
- Department of Osteoarthropathy, Yantaishan Hospital, Zhifu, Yantai, Shandong, China.
| | | | | |
Collapse
|
238
|
Hu WS, Liu W, Liu Y, Zhou Q, Yang ZC. [Epidemic characteristics and dynamic changes of spatio-temporal distribution of hemorrhagic fever with renal syndrome in Guangzhou, 2010-2019]. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41:2087-2092. [PMID: 33378821 DOI: 10.3760/cma.j.cn112338-20200522-00755] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Objective: To analyze the epidemic characteristics and spatio-temporal distribution of hemorrhagic fever with renal syndrome (HFRS) in Guangzhou from 2010 to 2019 and provide a basis for prevention and control strategies. Methods: The data of HFRS was from National Disease Reporting Information System and the epidemic investigation. A descriptive analysis was used. OpenGeoDa 1.2.0 software was used for global spatial autocorrelation and local spatial autocorrelation analysis. SatScan 9.6 software was used for detecting the hot spot area in time and space. ArcGIS 10.2 software was used for map visualization. Results: 1 298 cases of HFRS were reported, and three patients died in Guangzhou in 2010-2019. The annual incidence rate was 0.99/100 000. The proportion of 21-50 years old cases accounted for 70.88% and the male to female ratio was 2.98∶1. Most patients were house workers or unemployed, accounting for 31.28%, followed by business servants (accounting for 17.33%). The incidence peak in spring and winter accounted for 33.74% and 26.35% of the year. All districts reported cases in recent ten years. A total of 407 cases had been reported in Haizhu district, accounting for 31.36% of the total number of cases in the whole city. The annual incidence rate was 2.52/100 000. The number of reported cases and the annual incidence rate were the highest in Guangzhou. The clustered area showed that there was spatio-temporal clustering in Guangzhou. The aggregation area was mainly concentrated in the urban villages adjacent to Wan-mu orchard and the Haizhu Lake Wetland Park in Haizhu district (logarithmic likelihood ratio was 44.08, P<0.001). Conclusions: The prevalence and concentration of HFRS in winter and spring Guangzhou city from 2010 to 2019, showed a high incidence. Young and middle-aged men engaged in domestic and unemployed, and commercial services appeared the main risk groups. The urban-rural junction with many immigrants and low health environment, streets adjacent to Wan-mu orchard, and the Haizhu Lake Wetland Park in Haizhu district were the important regions for preventing and controlling HFRS. The government should formulate prevention and control measures to curb the rise and spread of the HFRS epidemic.
Collapse
Affiliation(s)
- W S Hu
- Business Management Department, Guangzhou Center for Disease Control and Prevention, Guangzhou 510440, China
| | - W Liu
- Business Management Department, Guangzhou Center for Disease Control and Prevention, Guangzhou 510440, China
| | - Y Liu
- Business Management Department, Guangzhou Center for Disease Control and Prevention, Guangzhou 510440, China
| | - Q Zhou
- Business Management Department, Guangzhou Center for Disease Control and Prevention, Guangzhou 510440, China
| | - Z C Yang
- Business Management Department, Guangzhou Center for Disease Control and Prevention, Guangzhou 510440, China
| |
Collapse
|
239
|
Liu W, Liu Y, Xu Z, Jiang T, Kang Y, Zhu G, Chen Z. Clinical characteristics and predictors of the duration of SARS-CoV-2 viral shedding in 140 healthcare workers. J Intern Med 2020; 288:725-736. [PMID: 32959400 PMCID: PMC7537050 DOI: 10.1111/joim.13160] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/07/2020] [Revised: 07/10/2020] [Accepted: 07/13/2020] [Indexed: 01/08/2023]
Abstract
BACKGROUND Epidemiological and clinical features of patients with COVID-19 have been reported, but none of them focused on medical staff, and few predictors of the duration of viral shedding have been reported. It is urgent to help healthcare workers prevent and recover quickly from the coronavirus disease 2019 (COVID-19). METHODS We enrolled 140 medical workers with COVID-19 in Wuhan. Epidemiological, demographic, clinical, laboratory, radiological treatment and clinical outcome data were collected, and predictors of the duration of viral shedding were explored through multivariable linear regression analysis. RESULTS The medical staff with COVID-19 presented mild clinical symptoms and showed a low frequency of abnormal laboratory indicators. All the medical staff were cured and discharged, of whom 96 (68.6%) were female, 39 (27.9%) had underlying diseases, the median age was 36.0 years, and 104 (74.3%) were infected whilst working in hospital. The median duration of viral shedding was 25.0 days (IQR:20.0-30.0). Multivariable linear regression analysis showed reducing viral shedding duration was associated with receiving recombinant human interferon alpha (rIFN-α) treatment, whilst the prolonged duration of viral shedding correlated with the use of glucocorticoid treatment, the durations from the first symptom to hospital admission and the improvement in chest computed tomography (CT) evidence. Moreover, infected healthcare workers with lymphocytes less than 1.1 × 109 /L on admission had prolonged viral shedding. CONCLUSION Medical staff with timely medical interventions show milder clinical features. Glucocorticoid treatment and lymphocytes less than 1.1 × 109/L are associated with prolonged viral shedding. Early admission and rIFN-α treatment help shorten the duration of viral shedding.
Collapse
Affiliation(s)
- W Liu
- From the, Department of Geriatrics, Renmin Hospital of Wuhan University, Wuhan, China
| | - Y Liu
- Department of Hand Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Z Xu
- Department of Hand Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - T Jiang
- Department of Hand Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Y Kang
- Department of Hand Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - G Zhu
- From the, Department of Geriatrics, Renmin Hospital of Wuhan University, Wuhan, China
| | - Z Chen
- Department of Hand Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| |
Collapse
|
240
|
Yang Y, Zhao X, Niu N, Zhao Y, Liu W, Moussian B, Zhang J. Two fatty acid synthase genes from the integument contribute to cuticular hydrocarbon biosynthesis and cuticle permeability in Locusta migratoria. Insect Mol Biol 2020; 29:555-568. [PMID: 32741000 DOI: 10.1111/imb.12665] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/30/2020] [Revised: 07/02/2020] [Accepted: 07/22/2020] [Indexed: 06/11/2023]
Abstract
Lipids of the insect cuticle have important roles in resistance against the arid environment and invasion of foreign substances. Fatty acid synthase (FAS) is an important enzyme of the insect lipid synthesis pathway. In the present study, we identified three FAS genes from transcriptome data of the migratory locust, Locusta migratoria, based on bioinformatics analyses. Among them, two FAS genes (LmFAS1 and LmFAS3) are highly expressed in the integument of fifth instar nymphs. Suppression of LmFAS1 and LmFAS3 by RNA interference caused lethality during ecdysis or shortly after moulting. The weight of the locusts and the content of lipid droplets were reduced compared with those of the control. The results of gas chromatography-mass spectrometry analysis showed that knockdown of LmFAS3 led to a decrease of both cuticular hydrocarbons and inner hydrocarbons (CHCs and IHCs) contents, especially the content of methyl branched hydrocarbons. By contrast, knockdown of LmFAS1 only resulted in a decrease in the IHC content, but not that of CHCs. By consequence, in LmFAS1- and LmFAS3-suppressed locusts, hydrocarbon deficiency reduced desiccation resistance and enhanced cuticle permeability and sensitivity to insecticides. These results indicate that LmFAS1 and LmFAS3 are essential for hydrocarbon production and cuticle permeability, which play influential roles in waterproofing the insect cuticle.
Collapse
Affiliation(s)
- Y Yang
- Institute of Applied Biology, Shanxi University, Taiyuan, China
- College of Life Science, Shanxi University, Taiyuan, China
| | - X Zhao
- Institute of Applied Biology, Shanxi University, Taiyuan, China
| | - N Niu
- Institute of Applied Biology, Shanxi University, Taiyuan, China
- College of Life Science, Shanxi University, Taiyuan, China
| | - Y Zhao
- Institute of Applied Biology, Shanxi University, Taiyuan, China
- College of Life Science, Shanxi University, Taiyuan, China
| | - W Liu
- Institute of Applied Biology, Shanxi University, Taiyuan, China
| | - B Moussian
- Université Côte d'Azur, CNRS, INSERM, Institute of Biology Valrose, Nice, France
| | - J Zhang
- Institute of Applied Biology, Shanxi University, Taiyuan, China
| |
Collapse
|
241
|
Liu W, Duan Z, Zhang C, Hu XX, Cao JB, Liu LJ., Lin L. Experimental observations and density functional simulations on the structural transition behavior of a two-dimensional transition-metal dichalcogenide. Sci Rep 2020; 10:18255. [PMID: 33106537 PMCID: PMC7588463 DOI: 10.1038/s41598-020-75240-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2020] [Accepted: 09/15/2020] [Indexed: 11/29/2022] Open
Abstract
In this work, we show an obvious evidence of nondestructive Raman spectra for the structural transition, i.e., the existence of a charge density wave (CDW) in monolayer 2H-TaS2, which can exhibit a much higher transition temperature than bulk and results in additional vibrational modes, indicating strong interactions with light. Furthermore, we reveal that the degenerate breath and wiggle modes of 2H-TaS2 originated from the periodic lattice distortion can be probed using the optical methods. Since recently several light-tunable devices have been proposed based on the CDW phase transition of 1 T-TaS2, our study and in particular, the theoretical results will be very helpful for understanding and designing electronic devices based on the CDW of 2H-TaS2.
Collapse
|
242
|
Zheng WH, Li C, Sun RH, Shui CY, Wang X, He TQ, Cai YC, Ning YD, Jiang J, Qin G, Zhou YQ, Liu W. [Advances in the research of central lymph node dissection for cN0 thyroid papillary carcinoma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2020; 55:799-803. [PMID: 32791784 DOI: 10.3760/cma.j.cn115330-20200411-00289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- W H Zheng
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Cancer Research Institute, Sichuan Cancer Prevention and Cure Center, Cancer Hospital Affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China; Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Southwest Medical University, Luzhou 646200, China
| | - C Li
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Cancer Research Institute, Sichuan Cancer Prevention and Cure Center, Cancer Hospital Affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China; Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Southwest Medical University, Luzhou 646200, China
| | - R H Sun
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Cancer Research Institute, Sichuan Cancer Prevention and Cure Center, Cancer Hospital Affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China
| | - C Y Shui
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Cancer Research Institute, Sichuan Cancer Prevention and Cure Center, Cancer Hospital Affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China
| | - X Wang
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Cancer Research Institute, Sichuan Cancer Prevention and Cure Center, Cancer Hospital Affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China; Department of Clinical Medicine, Chengdu Medical College, Chengdu 610041, China
| | - T Q He
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Cancer Research Institute, Sichuan Cancer Prevention and Cure Center, Cancer Hospital Affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China; Department of Clinical Medicine, Chengdu Medical College, Chengdu 610041, China
| | - Y C Cai
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Cancer Research Institute, Sichuan Cancer Prevention and Cure Center, Cancer Hospital Affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China
| | - Y D Ning
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Cancer Research Institute, Sichuan Cancer Prevention and Cure Center, Cancer Hospital Affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China
| | - J Jiang
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Cancer Research Institute, Sichuan Cancer Prevention and Cure Center, Cancer Hospital Affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China
| | - G Qin
- Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Southwest Medical University, Luzhou 646200, China
| | - Y Q Zhou
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Cancer Research Institute, Sichuan Cancer Prevention and Cure Center, Cancer Hospital Affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China
| | - W Liu
- Department of Head and Neck Surgery, Sichuan Cancer Hospital, Sichuan Cancer Research Institute, Sichuan Cancer Prevention and Cure Center, Cancer Hospital Affiliate to School of Medicine, Electronic Science and Technology, Chengdu 610041, China; Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Southwest Medical University, Luzhou 646200, China
| |
Collapse
|
243
|
Ji F, Liu W, Hao DA, Cheng J, Tong XC, Hao JG, Wang LP, Li CY, Dai MJ, Yan XB. Use of convalescent plasma therapy in eight individuals with mild COVID-19. New Microbes New Infect 2020; 39:100814. [PMID: 33204428 PMCID: PMC7661912 DOI: 10.1016/j.nmni.2020.100814] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2020] [Accepted: 11/08/2020] [Indexed: 12/28/2022] Open
Abstract
Coronavirus disease 2019 (COVID-19) is still a global epidemic. Several studies of individuals with severe COVID-19 regard convalescent plasma (CP) transfusion as an effective therapy. However, no significant improvements are found in randomized clinical trials of CP treatment. Until now, data for individuals with mild COVID-19 transfused CP were lacking. This study recruited eight individuals with mild COVID-19 who received at least one dose of CP transfusion. After CP therapy, the clinical symptoms of all individuals improved. Lymphocyte counts tended to increase, and lactate dehydrogenase, creatine kinase and aspartate aminotransferase tended to decrease. However, C-reactive protein increased transiently in three individuals. The median time for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid test to become negative was 2.5 days after CP transfusion. The study shows the potential benefits of CP. Meanwhile, CP probably enhances the inflammatory response to SARS-CoV-2 temporarily in people with insufficient antiviral immunity. However, the effects of CP are not permanent.
Collapse
Affiliation(s)
- F Ji
- Department of Infectious Disease, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
| | - W Liu
- Department of Infectious Disease, Fuyang Second Hospital, Fuyang, Anhui, China
| | - D-A Hao
- Department of Infectious Disease, Xuzhou Medical University, Xuzhou, Jiangsu, China
| | - J Cheng
- Department of Infectious Disease, Yancheng Second People's Hospital, Yancheng, Jiangsu, China
| | - X-C Tong
- Department of Infectious Disease, Changzhou Third People's Hospital, Jiangsu, China
| | - J-G Hao
- Department of Infectious Disease, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
| | - L-P Wang
- Department of Infectious Disease, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
| | - C-Y Li
- Department of Infectious Disease, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
| | - M-J Dai
- Department of Infectious Disease, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
| | - X-B Yan
- Department of Infectious Disease, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
| |
Collapse
|
244
|
Zhong ZR, Zhu QL, Li WW, Zhang GN, Wu B, Liu W, Ma L, Ren XY. [Ultrasound features and clinical characteristics of intestinal ischemia secondary to acute mesenteric venous thrombosis]. Zhonghua Wai Ke Za Zhi 2020; 58:864-869. [PMID: 33120450 DOI: 10.3760/cma.j.cn112139-20200330-00268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To examine the ultrasound features and clinical characteristics of the intestinal ischemia secondary to acute mesenteric venous thrombosis (AMVT). Methods: From January 2016 to June 2019, 11 patients were diagnosed as intestinal ischemia secondary to AMVT confirmed by surgical pathology or CT in Peking Union Medical College Hospital. The patients included 7 males and 4 females, aging of (52.8±11.9) years (range: 34 to 81 years).The clinical characters and ultrasound features were retrospectively reviewed. Results: Abdomen pain was the chief complaint of all patients. Other complaints include 2 cases of blood in the stool, 1 case of hematemesis, 2 cases of vomiting, 1 case of diarrhea. Six patients showed rebound pain on physical examination. All patients had elevated white blood cell account and D-Dimer. Nine patients had a thrombosis in the portal vein simultaneously. All 11 patients underwent the CT scan including 10 contrast-enhanced CT. Mesenteric venous thrombosis was detected in 10 cases who underwent contrast-enhanced CT imaging. On CT imaging, 11 patients demonstrated intestinal wall thicken, 5 patients showed intestinal dilation. Eight patients underwent superior mesenteric venous ultrasound examination. Of them, 7 patients were correctly diagnosed as AMVT. Of the 10 patients who underwent abdominal ultrasound, 5 patients showed intestinal lesions including intestinal wall thicken in 4 patients and intestinal dilation in 1 patient. Peritoneal fluid was detected in 10 patients by ultrasound, which was consistent with CT. Ten patients underwent surgical procedures while 1 patient received conservative treatment. Conclusion: Ultrasound is an accurate imaging method in diagnosing superior mesenteric vein thrombosis and can detect intestinal wall thickening, intestinal dilation, and peritoneal fluid.
Collapse
Affiliation(s)
- Z R Zhong
- Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China (is working on the Deaprtment of Ultrasound, Hospital of Tranditional Chinese Medicine of Zhongshan, Zhongshan 528400, Guangdong Province, China)
| | - Q L Zhu
- Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - W W Li
- Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - G N Zhang
- Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - B Wu
- Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - W Liu
- Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - L Ma
- Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - X Y Ren
- Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| |
Collapse
|
245
|
Huang CY, Li MY, Liu W, Li XX, Xu Y, Li JY, Yao QQ, Wang LM. Performance of prognostic nomogram in predicting long-term survival outcomes for osteosarcoma. J BIOL REG HOMEOS AG 2020; 34:1819-1824. [PMID: 33146004 DOI: 10.23812/20-105-l] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- C Y Huang
- Department of Orthopaedic Surgery, Nanjing First Hospital, Nanjing Medical University, China
| | - M Y Li
- Department of Cancer Recovery, Taikang Hospital, China
| | - W Liu
- Department of Orthopaedic Surgery, Affiliated Jiangsu Province Hospital of Nanjing Medical University, China
| | - X X Li
- Department of Orthopaedic Surgery, Nanjing First Hospital, Nanjing Medical University, China
| | - Y Xu
- Department of Orthopaedic Surgery, Nanjing First Hospital, Nanjing Medical University, China
| | - J Y Li
- Department of Orthopaedic Surgery, Nanjing First Hospital, Nanjing Medical University, China
| | - Q Q Yao
- Department of Orthopaedic Surgery, Nanjing First Hospital, Nanjing Medical University, China
| | - L M Wang
- Department of Orthopaedic Surgery, Nanjing First Hospital, Nanjing Medical University, China
| |
Collapse
|
246
|
Clémenson C, Liu W, Bricout D, Soyez-Herkert L, Chargari C, Mondini M, Haddad R, Wang-Zang X, Benel L, Bloy C, Deutsch E. PO-1803: Preventing Radioinduced Injury by Topical Application of an Amifostine Metabolite-Loaded Thermogel. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)01821-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
247
|
Kang J, Men Y, Wang J, Zhai Y, Deng L, Wang W, Liu W, Wang X, Bi N, Xiao Z, Liang J, Lv J, Zhou Z, Feng Q, Chen D, Wang L, Hui Z. Optimal Timing of Postoperative Radiotherapy (PORT) for Patients with pⅢA-N2 Non-Small Cell Lung Cancer (NSCLC) Receiving Complete Resection Followed by Adjuvant Chemotherapy. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.1293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
248
|
Gan Y, Du Q, Liu W, Li J, Jiang X, Li X, Ou X, Yue H, Zhu H, Zhong Q, Luo D, Liang Q, Xie Y, Zhang Q, Li G, Shang Y. Value Of Radiotherapy After Minimally Invasive Surgery In Patients With Stage IA1-IIA1 Cervical Cancer. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.1566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
249
|
Wang X, Zhang T, Deng L, Wang W, Liu W, Wang J, Zhai Y, Feng Q, LV J, Xiao Z, Chen D, Zhou Z, Bi N. Serial Circulating Tumor DNA for Evaluating Early Response During Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Preliminary Analysis of a Prospective Biomarker Study. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.2242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
250
|
Li N, Li T, Tang Y, Shi J, Liu W, Jin J, LI Y. Effectiveness Of Esophageal Gastric Junction Tumor Motion With And Without A Pneumatic Abdominal Compression In Precise IGRT Era. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.1943] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|